Heart valve sealing devices and delivery devices therefor
Patent Information
- Application Number
- HK62022065085
- Authority / Receiving Office
- HK · HK
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-12-23
- Filing Date
- 2022-12-04
- Publication Date
- 2026-09-04
- Estimated Expiration
- 2040-12-15
AI Technical Summary
Existing open-heart surgery for repairing damaged heart valves is highly invasive and can lead to complications. Transvascular techniques are also less effective at stopping retrograde blood flow when repairing heart valves.
A valve repair device, comprising a spacer, blades, and a leak control extension, is deployed to the patient's native valve via a delivery sheath. The blades move between open and closed positions, and the leak control extension prevents retrograde blood flow, thereby achieving valve repair.
It effectively repairs heart valves, reduces retrograde blood flow, avoids the invasiveness of open-heart surgery, and provides a safer treatment option.
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
[0001] Related applications
[0002] This application claims the benefit of U.S. Provisional Application No. 62 / 953,098, filed December 23, 2019, the entire contents of which are incorporated herein by reference for all purposes. Background Technology
[0003] Native heart valves (i.e., the aortic, pulmonary, tricuspid, and mitral valves) play a crucial role in ensuring an adequate supply of blood flows forward through the cardiovascular system. These valves can be damaged, for example, by congenital malformations, inflammatory processes, infections, and diseases, thus reducing their effectiveness. Such damage to the valves can lead to serious cardiovascular injury or death. During open-heart surgery, damaged valves can be repaired or replaced surgically. However, open-heart surgery is highly invasive and can result in complications. Transvascular techniques can be used to introduce and implant prosthetic devices in a much less invasive manner than open-heart surgery. As an example, one transvascular technique that can be used to access the native mitral and aortic valves is the transseptal technique. The transseptal technique involves advancing a catheter into the right atrium (e.g., inserting the catheter into the right femoral vein, then up the inferior vena cava, and into the right atrium). The septum is then punctured, and the catheter is inserted into the left atrium. Similar transvascular techniques can be used to implant a prosthetic device within the tricuspid valve, which initially works similarly to the transseptal technique but does not puncture the septum; instead, it redirects the delivery catheter toward the tricuspid valve in the right atrium.
[0004] A healthy heart has a roughly conical shape that tapers to a lower apex. The heart is four-chambered, consisting of the left atrium, right atrium, left ventricle, and right ventricle. The left and right sides of the heart are separated by walls commonly called septa. The native mitral valve of the human heart connects the left atrium to the left ventricle. The anatomy of the mitral valve is quite different from other native heart valves. The mitral valve consists of an annular portion, which is the ring-shaped portion of the native valve tissue surrounding the mitral orifice, and a pair of cusps or leaflets extending downwards from the annulus into the left ventricle. The mitral valve annulus can form a "D," elliptical, or other non-circular cross-sectional shape with a long axis and a short axis. The anterior leaflet can be larger than the posterior leaflet, forming a roughly "C"-shaped boundary between the adjacent sides of the leaflets when they are closed together.
[0005] When functioning correctly, the anterior and posterior leaflets together act as a one-way valve, allowing blood to flow only from the left atrium to the left ventricle. The left atrium receives oxygenated blood from the pulmonary veins. When the muscles of the left atrium contract and the left ventricle dilates (also known as "ventricular diastole" or "diastole"), the oxygenated blood collected in the left atrium flows into the left ventricle. When the muscles of the left atrium relax and the muscles of the left ventricle contract (also known as "ventricular systole" or "systole"), the increased blood pressure in the left ventricle pushes the two leaflets together, closing the one-way mitral valve and preventing blood from flowing back into the left atrium. Instead, it is expelled from the left ventricle through the aortic valve. To prevent the two leaflets from detaching under pressure and folding back into the left atrium through the mitral valve annulus, multiple fibrous cords called chordae tendineae attach the leaflets to the papillary muscles of the left ventricle.
[0006] Valvular regurgitation involves a valve improperly allowing some blood to flow through it in the wrong direction. For example, mitral regurgitation occurs when the native mitral valve fails to close properly and blood flows from the left ventricle to the left atrium during systole. Mitral regurgitation is one of the most common forms of valvular heart disease. Mitral regurgitation can have many different causes, such as leaflet prolapse, papillary muscle dysfunction, mitral valve annulus stretching due to left ventricular dilation, and more than one of these. Mitral regurgitation in the central part of the leaflet can be called central jet mitral regurgitation, and mitral regurgitation closer to a commissure (where the leaflets meet) can be called eccentric jet mitral regurgitation. Central jet regurgitation occurs when the edges of the leaflets do not meet in the middle and therefore the valve does not close, and regurgitation is present. Summary of the Invention
[0007] This summary is intended to provide examples and is not intended to limit the scope of the invention in any way. For example, the claims do not require any features included in the examples in this summary unless those features are expressly enumerated in the claims. Furthermore, the examples in this summary and the features, components, steps, concepts, etc., described elsewhere in this disclosure can be combined in various ways. Various features and steps as described elsewhere in this disclosure may be included in the examples summarized herein.
[0008] The patient's native valve can be repaired by attaching a spacer between the leaflets of the native valve. Retrograde blood flow through the spacer and the gap between the leaflets is blocked or inhibited.
[0009] An example valve repair device includes a septum, a pair of blades, and at least one leakage control extension. The pair of anchors (e.g., blades, latches, clamps, holders, fasteners, etc.) can be coupled to the septum. The pair of anchors (e.g., a pair of blades) is movable between an open position and a closed position and is configured to attach the valve repair device to the patient's native valve. At least one leakage control extension extends from the septum and is configured to prevent retrograde blood flow along the side of the septum.
[0010] An exemplary valve repair system includes a delivery sheath and a valve repair device. The valve repair device can be deployed to a patient's native valve via the delivery sheath. The valve repair device includes a septum, a pair of blades, and at least one leakage control extension. The pair of blades is coupled to the septum. The pair of blades is movable between an open position and a closed position and is configured to attach the valve repair device to the patient's native valve. At least one leakage control extension extends from the septum and is configured to block retrograde blood flow along the side of the septum.
[0011] In some embodiments, a valve repair device for repairing a patient’s native valve includes a spacer, a pair of anchors (e.g., blades, latches, clamps, holders, fasteners, etc.) configured to attach the valve repair device to the patient’s native valve, and at least one leak control extension extending from the spacer.
[0012] In some embodiments, the anchor pair is a pair of blades coupled to the spacer. In some embodiments, the pair of blades is movable between an open position and a closed position.
[0013] In some embodiments, at least one leak control extension extends from the spacer. The leak control extension is configured to block retrograde blood flow along the side of the spacer.
[0014] In some embodiments, the valve repair device further includes a cap connected to the spacer. In some embodiments, at least one leakage control extension is connected to the cap, which is connected to the spacer. In some embodiments, at least one leakage control extension is pivotally attached to the cap. In some embodiments, at least one leakage control extension is directly connected to the spacer.
[0015] In some embodiments, the valve repair device also includes a pair of snap fasteners, wherein a pair of anchors (e.g., a pair of blades) and the pair of snap fasteners are configured to attach the valve repair device to the patient's native valve.
[0016] In some implementations, the spacer is configured to close the gap in the patient's native valve when the valve repair device is attached to the native valve.
[0017] In some embodiments, at least one leakage control extension includes a deflector blade having a flexible wireframe covered by a cloth barrier material. The deflector blade can be connected to the spacer via one or more arms.
[0018] In some implementations, the flexible wireframe is configured to deform when positioned against the inner wall of the patient's heart.
[0019] In some embodiments, at least one leakage control extension includes a pocket, the pocket including a flexible wire frame defining an opening of the pocket and a fabric barrier material defining at least a portion of the interior of the pocket. In some embodiments, the opening of at least one leakage control extension is configured to be positioned below one or more leaflets of the native valve when the valve repair device is attached to the native valve. In some embodiments, the opening of at least one leakage control extension is configured to be positioned above the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0020] In some implementations, at least a portion of the leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0021] In some embodiments, the entire leakage control extension is configured to be positioned above the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve. In some embodiments, the entire leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0022] In some embodiments, at least one leakage control extension includes one or more deflector blades and a barrier element. In some embodiments, each of the one or more deflector blades has a flexible wireframe covered by a cloth barrier material. In some embodiments, the barrier element includes at least one of a cloth material, a biocompatible material, bovine or porcine heart tissue, and a plastic membrane.
[0023] In some embodiments, a valve repair device for repairing a native valve includes at least one anchor (e.g., a blade, latch, clamp, holder, fastener, etc.) and at least one leakage control extension, wherein the at least one anchor is configured to attach the valve repair device to the patient's native valve, and the at least one leakage control extension extends from a portion of the valve repair device.
[0024] In some implementations, at least one anchor can move between an open position and a closed position.
[0025] In some implementations, at least one leak control extension is configured to block retrograde blood flow to or near adjacent devices.
[0026] In some embodiments, the valve repair device further includes an engagement element (e.g., an occlusal element, a spacer, etc.). The engagement element is configured to close the gap in the patient's native valve when the valve repair device is attached to the native valve. In some embodiments, at least one leakage control extension extends from the engagement element and is configured to prevent retrograde blood flow along the side of the engagement element.
[0027] In some embodiments, the valve repair device further includes a cap connected to the coupling element. In some embodiments, at least one leakage control extension is directly connected to the coupling element. In some embodiments, at least one leakage control extension is connected to the cap, which is connected to the coupling element. In some embodiments, at least one leakage control extension is pivotally attached to the cap.
[0028] In some embodiments, at least one anchor is coupled to a coupling element. In some embodiments, at least one anchor includes a pair of blades coupled to the coupling element.
[0029] In some implementations, at least one anchor includes a pair of blades.
[0030] In some embodiments, the valve repair device further includes at least one snap fastener, wherein at least one anchor and at least one snap fastener are configured to attach the valve repair device to the patient’s native valve.
[0031] In some implementations, at least one snap-fit is coupled to the cap of the device.
[0032] In some embodiments, at least one leakage control extension includes a deflector blade having a flexible wireframe covered by a cloth barrier material. In some embodiments, the deflector blade is connected to a spacer via one or more arms. In some embodiments, the flexible wireframe is configured to deform when positioned against the patient's native valve inner wall.
[0033] In some embodiments, at least one leakage control extension includes a pocket comprising a flexible wire frame defining an opening of the pocket and a fabric barrier material defining at least a portion of the pocket's interior. In some embodiments, the opening of at least one leakage control extension is configured to be positioned below one or more leaflets of the native valve when the valve repair device is attached to the native valve. In some embodiments, the opening of at least one leakage control extension is configured to be positioned above the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0034] In some embodiments, at least a portion of the leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve. In some embodiments, the entire leakage control extension is configured to be positioned above the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve. In some embodiments, the entire leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0035] In some embodiments, at least one leakage control extension includes one or more deflector blades and a barrier element. In some embodiments, the one or more deflector blades have a flexible wireframe covered by a cloth barrier material. In some embodiments, the barrier element includes at least one of a cloth material, a biocompatible material, bovine or porcine heart tissue, and a plastic membrane.
[0036] In some implementations, a valve repair system for repairing a patient’s native valve includes a delivery sheath and a valve repair device that can be deployed to the patient’s native valve via the delivery sheath.
[0037] In some embodiments, the valve repair device includes a coupling element or spacer, a pair of blades (or other anchors) coupled to the spacer / coupling element, and at least one leakage control extension extending from the spacer / coupling element, wherein the leakage control extension is configured to prevent retrograde blood flow along the side of the spacer / coupling element.
[0038] In some implementations, a pair of blades (or other anchors) are movable between an open position and a closed position, wherein the pair of blades (or other anchors) are configured to attach the valve repair device to the patient's native valve.
[0039] In some embodiments, the system (e.g., a valve repair device for the system) also includes a cap connected to a spacer / joint element. In some embodiments, at least one leakage control extension is connected to the cap, which is connected to the spacer / joint element. In some embodiments, at least one leakage control extension is pivotally attached to the cap.
[0040] In some implementations, at least one leakage control extension is directly connected to the spacer / joint element.
[0041] In some implementations, the system (e.g., the valve repair device of the system) also includes a pair of clips, wherein a pair of blades (or other anchors) and a pair of clips are configured to attach the valve repair device to the patient’s native valve.
[0042] In some implementations, the spacer / joint element is configured to close the gap in the patient's native valve when the valve repair device is attached to the native valve.
[0043] In some embodiments, at least one leakage control extension includes a deflector blade having a flexible wireframe covered by a cloth barrier material. In some embodiments, the deflector blade is connected to a spacer via one or more arms. In some embodiments, the flexible wireframe is configured to deform when positioned against the inner wall of the patient's heart.
[0044] In some embodiments, at least one leakage control extension includes a pocket, the pocket including a flexible wire frame defining an opening of the pocket and a fabric barrier material defining at least a portion of the interior of the pocket. In some embodiments, the opening of at least one leakage control extension is configured to be positioned below one or more leaflets of the native valve when the valve repair device is attached to the native valve. In some embodiments, the opening of at least one leakage control extension is configured to be positioned above the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0045] In some implementations, at least a portion of the leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0046] In some embodiments, the entire leakage control extension is configured to be positioned above the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve. In some embodiments, the entire leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0047] In some embodiments, at least one leakage control extension includes one or more deflector blades and a barrier element. In some embodiments, each of the one or more deflector blades has a flexible wireframe covered by a cloth barrier material. In some embodiments, the barrier element includes at least one of a cloth material, a biocompatible material, bovine or porcine heart tissue, and a plastic membrane.
[0048] In some embodiments, a valve repair system for repairing a patient’s native valve includes a delivery sheath and a valve repair device that can be deployed to the patient’s native valve via the delivery sheath.
[0049] In some embodiments, the valve repair device includes at least one anchor (e.g., a blade, latch, clamp, holder, fastener, etc.) and at least one leak control extension extending from a portion of the device, wherein the leak control extension is configured to block retrograde blood flow adjacent to or near the device.
[0050] In some implementations, at least one anchor is movable between an open position and a closed position, wherein a pair of blades are configured to attach the valve repair device to the patient’s native valve;
[0051] In some implementations, the system (e.g., the valve repair device of the system) also includes engagement elements (e.g., spacers, occlusion elements, etc.).
[0052] In some embodiments, at least one leakage control extension extends from the engagement element and is configured to block retrograde blood flow along the side of the engagement element.
[0053] In some implementations, the system (e.g., the system's valve repair device) also includes a cap connected to the coupling element.
[0054] In some implementations, at least one leakage control extension is directly connected to the coupling element.
[0055] In some implementations, at least one leakage control extension is connected to a cap, which is connected to a coupling element.
[0056] In some implementations, at least one leak control extension is pivotally attached to the cap.
[0057] In some embodiments, at least one anchor is coupled to a coupling element. In some embodiments, at least one anchor includes a pair of blades coupled to the coupling element.
[0058] In some implementations, at least one anchor includes a pair of blades.
[0059] In some implementations, the coupling element is configured to close the gap in the patient's native valve when the valve repair device is attached to the native valve.
[0060] In some embodiments, the system further includes at least one pair of snaps, wherein at least one anchor and at least one snap are configured to attach the valve repair device to the patient's native valve. In some embodiments, at least one snap is coupled to the cap of the device.
[0061] In some embodiments, at least one leakage control extension includes a deflector blade having a flexible wireframe covered by a cloth barrier material. In some embodiments, the deflector blade is connected to a coupling element via one or more arms. In some embodiments, the flexible wireframe is configured to deform when positioned against the patient's native valve inner wall.
[0062] In some embodiments, at least one leak control extension includes a pocket, the pocket including a flexible wireframe defining an opening of the pocket and a fabric barrier material defining at least a portion of the interior of the pocket.
[0063] In some embodiments, the opening of at least one leakage control extension is configured to be positioned below one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0064] In some embodiments, the opening of at least one leakage control extension is configured to be positioned above the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0065] In some implementations, at least a portion of the leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0066] In some embodiments, the entire leakage control extension is configured to be positioned above the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve. In some embodiments, the entire leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the native valve when the valve repair device is attached to the native valve.
[0067] In some embodiments, at least one leakage control extension includes one or more deflector blades and a barrier element. In some embodiments, each of the one or more deflector blades has a flexible wireframe covered by a cloth barrier material. In some embodiments, the barrier element includes at least one of a cloth material, a biocompatible material, bovine or porcine heart tissue, and a plastic membrane.
[0068] In some implementations, methods for repairing a patient’s native valve include attaching a spacer or connecting element between the leaflets of the patient’s native valve and blocking retrograde blood flow through the gap between the spacer and the leaflets.
[0069] In some implementations, retrograde blood flow through the gap is blocked and the gap is not filled.
[0070] In some implementations, retrograde blood flow through the gap is blocked without filling any part of the gap.
[0071] In some implementations, retrograde blood flow is blocked at least partially by an extension located on the ventricular side of the leaflet.
[0072] In some implementations, retrograde blood flow is blocked by an extension located entirely on the ventricular side of the leaflet.
[0073] In some embodiments, the method further includes positioning spacers to deform one or more of the extensions against the inner wall of the patient's heart.
[0074] The above-described methods (one or more) can be performed on live animals or simulations, such as on corpses, corpse hearts, simulators (e.g., simulating body parts, hearts, tissues, etc.).
[0075] A further understanding of the nature and advantages of the invention is set forth in the following description and claims, particularly when considered in conjunction with the accompanying drawings, in which the same parts have the same reference numerals. Attached Figure Description
[0076] To further clarify various aspects of the embodiments of this disclosure, exemplary embodiments will be described in more detail with reference to various aspects of the accompanying drawings. It should be understood that these drawings depict only typical embodiments of this disclosure and should not be considered as limiting the scope of this disclosure. Furthermore, while the drawings may be drawn to scale for some embodiments, they are not necessarily drawn to scale for all embodiments. Embodiments of this disclosure and other features and advantages will be described and explained with additional specificity and detail using the accompanying drawings, in which:
[0077] Figure 1 The illustration shows a cross-sectional view of the human heart during diastole.
[0078] Figure 2 The illustration shows a cross-sectional view of the human heart during systole.
[0079] Figure 3 The illustration shows a cross-sectional view of the human heart in diastole, showing the chordae tendineae attaching the leaflets of the mitral and tricuspid valves to the ventricular wall.
[0080] Figure 4 The illustration shows a healthy mitral valve with leaflet closure when viewed from the atrial side.
[0081] Figure 5 The illustration shows a dysfunctional mitral valve with visible gaps between the leaflets when viewed from the atrial side.
[0082] Figure 6 The illustration shows the mitral valve with a wide gap between the posterior and anterior leaflets;
[0083] Figure 7 The diagram shows the tricuspid valve as viewed from the atrial side.
[0084] Figures 8-14 Examples of implantable prosthetic devices at various stages of deployment are shown;
[0085] Figures 15-20 Showing Figures 8-14 An implantable prosthesis is delivered and implanted into the native valve;
[0086] Figure 21 Showing implanted within the native valve Figures 8-14 Implantable prosthetic devices;
[0087] Figure 22 An implantable prosthesis device is shown at a first example location within the native valve;
[0088] Figure 23 Is implanted in Figure 22 The diagram shows a cross-sectional view of an implantable prosthesis device at a first location within the native valve, with the cross-section along... Figure 22 The plane intercept indicated by line 23-23 in the middle;
[0089] Figure 24 The implantation is shown as viewed from the ventricular side of the native valve. Figure 22 The implantable prosthesis device is shown at the first location within the native valve.
[0090] Figure 25 The implantation was shown as viewed from the atrial side of the native valve. Figure 22 The implantable prosthesis device is shown at the first location within the native valve.
[0091] Figure 26 This shows a second example location of the implanted native valve, viewed from the ventricular side. Figure 22 Implantable prosthetic devices;
[0092] Figure 27 The implantation was shown as viewed from the atrial side of the native valve. Figure 26 The second example location within the native valve shown Figure 22 Implantable prosthetic devices;
[0093] Figure 28 An example of an implantable prosthesis device is shown at a first example location within the native valve;
[0094] Figure 29 Is implanted in Figure 28 The diagram shows a cross-sectional view of the implantable prosthesis device at the first location within the native valve, with the cross-section along... Figure 28 The plane intercept indicated by line 29-29 in the middle;
[0095] Figure 30 The implantation was observed during the diastolic phase of the heart. Figure 28 The implantable prosthesis device is shown at the first location within the valve.
[0096] Figure 31 Is implanted in Figure 30 The diagram shows a cross-sectional view of the implantable prosthesis device at the first location within the native valve, with the cross-section along... Figure 30 The plane cut indicated by line 31-31 shown;
[0097] Figure 32 The image shows the implantation during cardiac systole. Figure 28 The implantable prosthesis device is shown at the first location within the valve.
[0098] Figure 33 Is implanted in Figure 32 The diagram shows a cross-sectional view of the implantable prosthesis device at the first location within the native valve, with the cross-section along... Figure 32 The plane intercept indicated by line 33-33 shown;
[0099] Figure 34 The implantation is shown as viewed from the ventricular side of the native valve. Figure 28 The implantable prosthesis device is shown at the first location within the native valve.
[0100] Figure 35 The implantation was shown as viewed from the atrial side of the native valve. Figure 28 The implantable prosthesis device is shown at the first location within the native valve.
[0101] Figure 36 This shows a second example location of the implanted native valve, viewed from the ventricular side. Figure 28 Implantable prosthetic devices;
[0102] Figure 37 The implantation was shown as viewed from the atrial side of the native valve. Figure 36 The second example location within the native valve shown Figure 28 Implantable prosthetic devices;
[0103] Figure 38A An example of an implantable prosthesis device is shown at a first example location within the native valve;
[0104] Figure 38B An example of an implantable prosthesis device is shown at a first example location within the native valve;
[0105] Figure 39A Is implanted in Figure 38A The diagram shows a cross-sectional view of the implantable prosthesis device at the first location within the native valve, with the cross-section along... Figure 38A The plane intercept indicated by line 39A-39A in the middle;
[0106] Figure 39B Is implanted in Figure 38B The diagram shows a cross-sectional view of the implantable prosthesis device at the first location within the native valve, with the cross-section along... Figure 38B The plane intercept indicated by line 39B-39B in the middle;
[0107] Figure 40A The implantation was observed during the diastolic phase of the heart. Figure 38AThe implantable prosthesis device is shown at the first location within the native valve.
[0108] Figure 40B The implantation was observed during the diastolic phase of the heart. Figure 38B The implantable prosthesis device is shown at the first location within the native valve.
[0109] Figure 41A Is implanted in Figure 40A The cross-sectional view of the implantable prosthesis device at a first location within the native valve is shown, wherein the cross-section is along... Figure 40A The plane cut indicated by lines 41A-41A shown in the diagram;
[0110] Figure 41B Is implanted in Figure 40B The cross-sectional view of the implantable prosthesis device at a first location within the native valve is shown, wherein the cross-section is along... Figure 40B The plane cut indicated by lines 41B-41B shown in the diagram;
[0111] Figure 42A The image shows the implantation during cardiac systole. Figure 38A The implantable prosthesis device is shown at the first location within the native valve.
[0112] Figure 42B The image shows the implantation during cardiac systole. Figure 38B The implantable prosthesis device is shown at the first location within the native valve.
[0113] Figure 43A Is implanted in Figure 42A The diagram shows a cross-sectional view of an implantable prosthesis device at a first location within the native valve, wherein the cross-section is along... Figure 42A The plane intercept indicated by line 43A-43A is shown;
[0114] Figure 43B Is implanted in Figure 42B The cross-sectional view of the implantable prosthesis device at a first location within the native valve is shown, wherein the cross-section is along... Figure 42B The plane cut indicated by lines 43B-43B shown in the diagram;
[0115] Figure 44A The implantation is shown as viewed from the ventricular side of the native valve. Figure 38A The implantable prosthesis device is shown at the first location within the native valve.
[0116] Figure 44B The implantation is shown as viewed from the ventricular side of the native valve. Figure 38B The implantable prosthesis device is shown at the first location within the native valve.
[0117] Figure 45A The implantation was shown as viewed from the atrial side of the native valve. Figure 38A The implantable prosthesis device is shown at the first location within the native valve.
[0118] Figure 45B The implantation was shown as viewed from the atrial side of the native valve. Figure 38B The implantable prosthesis device is shown at the first location within the native valve.
[0119] Figure 46A This shows a second example location of implantation within the native valve, viewed from the ventricular side. Figure 38A Implantable prosthetic devices;
[0120] Figure 46B This shows a second example location of implantation within the native valve, viewed from the ventricular side. Figure 38B Implantable prosthetic devices;
[0121] Figure 47A The implantation was shown as viewed from the atrial side of the native valve. Figure 46A The second example location within the mitral valve is shown. Figure 38A Implantable prosthetic devices;
[0122] Figure 47B The implantation was observed from the atrial side of the native valve. Figure 46B The second example location within the mitral valve is shown. Figure 38B Implantable prosthetic devices;
[0123] Figure 48A An example of an implantable prosthesis device is shown at a first example location within the native valve;
[0124] Figure 48B An example of an implantable prosthesis device is shown at a first example location within the native valve;
[0125] Figure 49A Is implanted in Figure 48A The diagram shows a cross-sectional view of an implantable prosthesis device at a first location within the native valve, wherein the cross-section is along... Figure 48A The plane intercept indicated by line 49A-49A in the middle;
[0126] Figure 49B Is implanted in Figure 48B The diagram shows a cross-sectional view of an implantable prosthesis device at a first location within the native valve, wherein the cross-section is along... Figure 48B The plane intercept indicated by line 49B-49B in the middle;
[0127] Figure 50A The implantation was observed during the diastolic phase of the heart. Figure 48AThe implantable prosthesis device is shown at the first location within the native valve.
[0128] Figure 50B The implantation was observed during the diastolic phase of the heart. Figure 48B The implantable prosthesis device is shown at the first location within the native valve.
[0129] Figure 51A Is implanted in Figure 50A The cross-sectional view of the implantable prosthesis device at the first location within the native valve is shown. Figure 50A The plane cut indicated by lines 51A-51A shown in the diagram;
[0130] Figure 51B Is implanted in Figure 50B The cross-sectional view of the implantable prosthesis device at the first location within the native valve is shown. Figure 50B The plane cut indicated by lines 51B-51B shown in the diagram;
[0131] Figure 52A The image shows the implantation during cardiac systole. Figure 48A The implantable prosthesis device is shown at the first location within the native valve.
[0132] Figure 52B The image shows the implantation during cardiac systole. Figure 48B The implantable prosthesis device is shown at the first location within the native valve.
[0133] Figure 53A Is implanted in Figure 52A The diagram shows a cross-sectional view of the implantable prosthesis device at the first location within the native valve, with the cross-section along... Figure 52A The plane section indicated by line 53A-53A is shown;
[0134] Figure 53B Is implanted in Figure 52B The cross-sectional view of the implantable prosthesis device at the first location within the native valve is shown. Figure 52B The plane cut indicated by lines 53B-53B shown in the diagram;
[0135] Figure 54A The implantation is shown as viewed from the ventricular side of the native valve. Figure 48A The implantable prosthesis device is shown at the first location within the native valve.
[0136] Figure 54B The implantation is shown as viewed from the ventricular side of the native valve. Figure 48B The implantable prosthesis device is shown at the first location within the native valve.
[0137] Figure 55AThe implantation was shown as viewed from the atrial side of the native valve. Figure 48A The implantable prosthesis device is shown at the first location within the native valve.
[0138] Figure 55B The implantation was shown as viewed from the atrial side of the native valve. Figure 48B The implantable prosthesis device is shown at the first location within the native valve.
[0139] Figure 56A This shows a second example location of implantation within the native valve, viewed from the ventricular side. Figure 48A Implantable prosthetic devices;
[0140] Figure 56B This shows a second example location of implantation within the native valve, viewed from the ventricular side. Figure 48B Implantable prosthetic devices;
[0141] Figure 57A Showing Figure 48A An implantable prosthetic device that is implanted in Figure 56A The second example location within the native valve is shown, and viewed from the atrial side of the native valve;
[0142] Figure 57B Showing Figure 48B An implantable prosthesis device that is implanted Figure 56B The second example location within the native valve is shown, and viewed from the atrial side of the native valve;
[0143] Figure 58 An example of an implantable prosthesis device is shown at a first example location within the native valve;
[0144] Figure 59 Is implanted in Figure 58 The diagram shows a cross-sectional view of the implantable prosthesis device at the first location within the native valve, with the cross-section along... Figure 58 The plane intercept indicated by line 59-59 in the middle;
[0145] Figure 60 The implantation was observed during the diastolic phase of the heart. Figure 58 The implantable prosthesis device is shown at the first location within the native valve.
[0146] Figure 61 Is implanted in Figure 60 The cross-sectional view of the implantable prosthesis device at a first location within the native valve is shown, wherein the cross-section is along... Figure 60 The plane cut indicated by lines 61-61 shown in the diagram;
[0147] Figure 62The image shows the implantation during cardiac systole. Figure 58 The implantable prosthesis device is shown at the first location within the native valve.
[0148] Figure 63 It is along Figure 62 The lines shown in line 63-63 are observed and implanted in Figure 62 A cross-sectional view of an implantable prosthesis device at the first location within the native valve;
[0149] Figure 64 The implantation is shown as viewed from the ventricular side of the native valve. Figure 58 The implantable prosthesis device is shown at the first location within the native valve.
[0150] Figure 65 The implantation was shown as viewed from the atrial side of the native valve. Figure 58 The implantable prosthesis device is shown at the first location within the native valve.
[0151] Figure 66 Showing Figure 58 An implantable prosthetic device is implanted at a second example location within the native valve and viewed from the ventricular side of the native valve.
[0152] Figure 67 Showing Figure 58 An implantable prosthetic device that is implanted in Figure 66 The second example location within the native valve is shown, and viewed from the atrial side of the native valve;
[0153] Figure 68 An example of an implantable prosthesis device is shown at a first example location within the native valve;
[0154] Figure 69 Is implanted in Figure 68 The cross-sectional view of the implantable prosthesis device at the first location within the native valve is shown. Figure 68 The plane intercept indicated by line 69-69 in the middle;
[0155] Figure 70 The implantation was observed during the diastolic phase of the heart. Figure 68 An implantable prosthesis device is shown at the first location within the valve.
[0156] Figure 71 Is implanted in Figure 70 The diagram shows a cross-sectional view of the implantable prosthesis device at the first location within the native valve, with the cross-section along... Figure 70 The plane section indicated by line 71-71 is shown;
[0157] Figure 72The image shows the implantation during cardiac systole. Figure 68 An implantable prosthesis device is shown at the first location within the valve.
[0158] Figure 73 Is implanted in Figure 72 The diagram shows a cross-sectional view of the implantable prosthesis device at the first location within the native valve, with the cross-section along... Figure 72 The plane section indicated by line 73-73 is shown;
[0159] Figure 74 The implantation is shown as viewed from the ventricular side of the native valve. Figure 68 The implantable prosthesis device is shown at the first location within the native valve.
[0160] Figure 75 The implantation was shown as viewed from the atrial side of the native valve. Figure 68 The implantable prosthesis device is shown at the first location within the native valve.
[0161] Figure 76 Showing Figure 68 An implantable prosthetic device is implanted at a second example location within the native valve and viewed from the ventricular side of the native valve.
[0162] Figure 77 Showing Figure 68 An implantable prosthetic device that is implanted in Figure 76 The second example location within the native valve is shown, and viewed from the atrial side of the native valve;
[0163] Figure 78 yes Figures 38A-47A A bottom view of a more specific example of the implantable prosthesis device shown;
[0164] Figure 79 yes Figures 38A-47A A bottom view of a more specific example of the implantable prosthesis device shown;
[0165] Figure 80 yes Figures 48A-57A A front view of a more specific example of the implantable prosthesis device shown;
[0166] Figure 81 yes Figure 80 A bottom view of the implantable prosthesis device shown;
[0167] Figure 82 An example of an implantable prosthesis device is shown at a first example location within the native valve;
[0168] Figure 83 Is implanted in Figure 82The diagram shows a cross-sectional view of the implantable prosthesis device at the first location within the native valve, with the cross-section along... Figure 82 The plane intercept indicated by line 83-83 in the middle;
[0169] Figure 84 The implantation was observed during the diastolic phase of the heart. Figure 82 The implantable prosthesis device is shown at the first location within the native valve.
[0170] Figure 85 Is implanted in Figure 84 The diagram shows a cross-sectional view of the implantable prosthesis device at the first location within the native valve, with the cross-section along... Figure 84 The plane cut indicated by line 85-85 is shown;
[0171] Figure 86 The image shows the implantation during cardiac systole. Figure 82 The implantable prosthesis device is shown at the first location within the native valve.
[0172] Figure 87 It is along Figure 86 The lines shown in line 87-87 are observed and implanted in Figure 86 A cross-sectional view of an implantable prosthesis device at the first location within the native valve;
[0173] Figure 88 The implantation is shown as viewed from the ventricular side of the native valve. Figure 82 The implantable prosthesis device is shown at the first location within the native valve.
[0174] Figure 89 The implantation was shown as viewed from the atrial side of the native valve. Figure 82 The implantable prosthesis device is shown at the first location within the native valve.
[0175] Figure 90 Showing Figure 82 An implantable prosthetic device, implanted at a second example location within the native valve, and viewed from the ventricular side of the native valve; and
[0176] Figure 91 Showing Figure 82 An implantable prosthetic device that is implanted in Figure 90 The second example location within the native valve is shown, and viewed from the atrial side of the native valve. Detailed Implementation
[0177] The following description refers to the accompanying drawings, which illustrate specific embodiments of the present disclosure. Other embodiments with different structures and operations do not depart from the scope of this disclosure.
[0178] This disclosure relates to exemplary embodiments of systems, apparatuses, methods, etc., for repairing defective heart valves. It should be noted that various embodiments of native valve repair devices, systems for delivering native valve repair devices, and systems for removing implanted native valve repair devices are disclosed herein, and any combination of these options is permissible unless specifically excluded. In other words, the various components of the disclosed apparatuses and systems can be combined unless mutually exclusive or otherwise physically impossible. Furthermore, these techniques and methods can be performed on living animals or simulants, such as cadavers, cadaver hearts, simulators (e.g., simulating body parts, hearts, tissues, etc.).
[0179] As described herein, when one or more components are described as connected, linked, attached, coupled, interposed, or otherwise interconnected, such interconnection may be direct between components or indirect, for example, through the use of one or more intermediate components. Furthermore, as described herein, references to “component,” “part,” or “section” should not be limited to a single structural component, part, or element, but may include assemblies of components, components, or elements. Additionally, as described herein, the terms “substantially” and “approximately” are defined as at least close to (and including) a given value or state (preferably within 10%, more preferably within 1%, and most preferably within 0.1%).
[0180] Figure 1 and Figure 2 These are cross-sectional views of the human heart (H) during diastole and systole. The right ventricle (RV) and left ventricle (LV) are separated from the right atrium (RA) and left atrium (LA) by the tricuspid valve (TV) and mitral valve (MV), respectively; these are the atrioventricular valves. Furthermore, the aortic valve (AV) separates the left ventricle (LV) from the ascending aorta (AA), and the pulmonary valve (PV) separates the right ventricle from the pulmonary artery (PA). Each of these valves has flexible leaflets (e.g., Figure 4 and Figure 5 The leaflets 20 and 22 shown in the diagram extend inward through corresponding orifices that converge or "coapt" in the fluid flow to form a unidirectional fluid-blocking surface. The native valve repair system of this application is primarily described for the mitral valve (MV). Therefore, the anatomy of the left atrial valve (LA) and left ventricular valve (LV) will be explained in more detail. However, the device described herein can also be used to repair other native valves, such as the tricuspid valve (TV), aortic valve (AV), and pulmonary valve (PV).
[0181] The left atrium (LA) receives oxygenated blood from the lungs. During diastole or relaxation, such as... Figure 1 As shown, blood previously collected in the left atrium (LA) during systole moves through the mitral valve (MV) and into the left ventricle (LV) via the expansion of the left ventricle (LV). During systole or contraction, as... Figure 2As shown, the left ventricle (LV) contracts to force blood through the aortic valve (AV) and ascending aorta (AA) into the body. During contraction, the leaflets of the mitral valve (MV) close to prevent blood from regurgitating from the left ventricle (LV) back into the left atrium (LA), and blood is collected from the pulmonary veins into the left atrium. In one example embodiment, the devices described in this application are used to restore the function of a defective mitral valve (MV). That is, these devices are configured to help close the leaflets of the mitral valve to prevent blood from regurgitating from the left ventricle (LV) back into the left atrium (LA).
[0182] Now for reference Figures 1-7 The mitral valve MV comprises two leaflets, an anterior leaflet 20 and a posterior leaflet 22. The mitral valve MV also includes a valve annulus 24, which is a variable-density annulus of tissue fibers surrounding the leaflets 20 and 22. (Reference) Figure 3 The mitral valve MV is anchored to the wall of the left ventricle (LV) via chordae tendineae 10. Chordalae 10 are cord-like tendons that connect papillary muscles 12 (i.e., muscles located at the base of the chordae tendineae and within the left ventricular wall) to the leaflets 20 and 22 of the mitral valve MV. Papillary muscles 12 restrict the movement of the mitral valve MV and prevent mitral valve reversion. The mitral valve MV opens and closes in response to pressure changes in the left atrium (LA) and left ventricle (LV). The papillary muscles do not open or close the mitral valve MV. Instead, they support the mitral valve MV against the high pressure required for blood circulation throughout the body. Together with the chordae tendineae, the papillary muscles are referred to as the subvalvular device, and their function is to prevent the mitral valve MV from prolapsed into the left atrium (LA) during mitral valve closure.
[0183] Various disease processes can impair the normal function of one or more of the heart's primary valves (Vol. H). These processes include degenerative processes (e.g., Barlow's disease, lack of fibroelastosis), inflammatory processes (e.g., rheumatic heart disease), and infectious processes (e.g., endocarditis). Furthermore, damage to the left ventricle (LV) or right ventricle (RV) from a previous heart attack (i.e., a myocardial infarction secondary to coronary artery disease) or other heart diseases (e.g., cardiomyopathy) can distort the geometry of the primary valve, leading to its dysfunction. However, the vast majority of patients undergoing valve surgery, such as mitral valve MV surgery, have degenerative diseases that cause dysfunction of the leaflets (e.g., leaflets 20, 22) of the primary valve (e.g., mitral valve MV), leading to prolapse and regurgitation.
[0184] Typically, the native valve can malfunction in two different ways: (1) valvular stenosis; and (2) valvular regurgitation. Valvular stenosis occurs when the native valve does not open fully and thus obstructs blood flow. Typically, valvular stenosis is caused by the accumulation of calcified material on the leaflets, which causes the leaflets to thicken and impairs the valve's ability to open fully to allow blood to flow forward.
[0185] The second type of valvular dysfunction, valvular regurgitation, occurs when the leaflets of the valve fail to close completely, causing blood to leak back into the previous chamber (e.g., causing blood to leak from the left ventricle into the left atrium). There are three mechanisms that lead to primary valve regurgitation or dysfunction—including Carpentier's Type I, II, and III failures. Carpentier's Type I failure involves annular dilation, causing the normally functioning leaflets to separate from each other and fail to form a tight seal (i.e., the leaflets do not properly mate). Type I mechanism failure includes leaflet perforation, as seen in endocarditis. Carpentier's Type II failure involves one or more leaflets of the primary valve detaching above the occlusal plane. Carpentier's Type III failure involves restricting the movement of one or more leaflets of the primary valve, causing the leaflets to be abnormally confined below the annular plane. Rheumatism (Ma) or ventricular dilatation (IIIb) can cause leaflet restriction.
[0186] refer to Figure 4 When a healthy mitral valve (MV) is in the closed position, the anterior leaflet 20 and posterior leaflet 22 engage, preventing blood from leaking from the left ventricle (LV) into the left atrium (LA). (Reference) Figure 5 Regurgitation occurs when the anterior leaflet 20 and / or posterior leaflet 22 of the mitral valve MV shifts into the left atrium LA during systole. This failure to engage results in a gap 26 between the anterior leaflet 20 and the posterior leaflet 22, which allows blood to flow from the left ventricle LV back to the left atrium LA during systole. As mentioned above, leaflets (e.g., leaflets 20, 22 of the mitral valve MV) can malfunction in several different ways, potentially leading to regurgitation.
[0187] Reference Figure 6 In some cases, when the mitral valve is in the closed position (i.e., during systole), the patient's mitral valve MV may have a wide gap 26 between the anterior leaflet 20 and the posterior leaflet 22. For example, the gap 26 may have a width W between about 2.5 mm and about 17.5 mm (e.g., between about 5 mm and about 15 mm, or between about 7.5 mm and about 12.5 mm, or about 10 mm). In some cases, the gap 26 may have a width W greater than 15 mm. In any of the above cases, it is desirable that the valve repair device can engage the anterior leaflet 20 and the posterior leaflet 22 to close the gap 26 and prevent blood regurgitation through the mitral valve MV.
[0188] Although stenosis or regurgitation can affect any valve, stenosis is found to primarily affect the aortic valve (AV) or pulmonary valve (PV), and regurgitation is found to primarily affect the mitral valve (MV) or tricuspid valve (TV). Both valvular stenosis and regurgitation increase the workload on the heart and can lead to very serious conditions if left untreated, such as endocarditis, congestive heart failure, permanent heart damage, cardiac arrest, and ultimately death. Because the left side of the heart (i.e., the left atrium (LA), left ventricle (LV), mitral valve (MV), and aortic valve (AV)) is primarily responsible for circulating blood throughout the body, dysfunction of the mitral valve (MV) or aortic valve (AV) is particularly problematic and often life-threatening. Therefore, due to the significantly higher pressure on the left side of the heart, dysfunction of the mitral valve (MV) or aortic valve (AV) is more problematic.
[0189] Failed native heart valves can be repaired or replaced. Repair typically involves preserving and correcting the patient's native valve. Replacement typically involves replacing the patient's native valve with a biological or mechanical substitute. Aortic valves (AV) and pulmonary valves (PV) are generally more prone to stenosis. Because stenosis caused by leaflets is irreversible, the most routine treatment for a stenotic aortic or pulmonary valve is to remove and replace the valve with a surgically implanted heart valve or to replace it with a transcatheter heart valve. Mitral valves (MV) and tricuspid valves (TV) are more prone to leaflet deformation, which, as described above, prevents the mitral or tricuspid valves from closing properly and allows blood to regurgitate from the ventricle or flow back into the atrium (e.g., a deformed mitral valve MV may allow regurgitation from the left ventricle (LV) or flow back into the left atrium (LA). Blood regurgitation from the ventricle or flow back into the atrium leads to valvular insufficiency. Deformations in the structure or shape of mitral valve MV or tricuspid valve TV are repairable. Furthermore, regurgitation can occur as the chordae tendineae 10 become dysfunctional (e.g., the chordae tendineae may stretch or rupture), which allows the anterior leaflet 20 and posterior leaflet 22 to recover, allowing blood to flow back into the left atrium LA. Problems caused by dysfunctional chordae tendineae can be repaired by repairing the structure of the chordae tendineae or the mitral valve (e.g., by fixing leaflets 20, 22 to the affected portion of the mitral valve).
[0190] The devices and procedures disclosed herein relate to the repair of mitral valve structures or the removal of implanted repair devices from the mitral valve. However, it should be understood that the devices and concepts provided herein can be used to repair any native valve or any component of a native valve. Reference now. Figure 7Any device and concept provided herein can be used to repair tricuspid valve reflux (TV). For example, the device and concept provided herein can be used between any two of the anterior leaflet 30, septal leaflet 32, and posterior leaflet 34 to prevent blood regurgitation from the right ventricle to the right atrium. Furthermore, any device and concept provided herein can be used together for all three leaflets 30, 32, and 34 to prevent blood regurgitation from the right ventricle to the right atrium. That is, the valve repair device provided herein can be located centrally between the three leaflets 30, 32, and 34.
[0191] The concepts disclosed in this patent application can be applied to a variety of different valve repair devices. Examples of valve repair devices to which the concepts disclosed herein can be applied are disclosed in U.S. Provisional Patent Application Serial No. 62 / 744,031, filed October 10, 2018; Patent Cooperation Treaty Application No. PCT / US2019 / 012707, filed January 8, 2019; and Patent Cooperation Treaty Application No. PCT / US2018 / 028189, all of which are incorporated herein by reference.
[0192] Figures 8-14 An example of a valve repair device is illustrated. An exemplary implantable prosthetic device may have an occlusal or engagement element (e.g., a spacer, etc.) and at least one anchor. The engagement element is configured to be positioned within the orifice of the native heart valve to help fill the space and form a more effective seal, thereby reducing or preventing the aforementioned regurgitation. The engagement element may have a blood-impermeable structure, and this structure allows the native leaflet to close around the engagement element during ventricular systole to prevent blood from flowing from the left or right ventricle back into the left or right atrium, respectively. The prosthetic device may be configured to seal two or three native valve leaflets; that is, the device can be used for both the native mitral valve (mitral valve) and the tricuspid valve. The engagement element is sometimes referred to herein as a spacer because the engagement element can fill the space between the leaflets of a dysfunctional native mitral or tricuspid valve that has not closed completely.
[0193] The engaging element (e.g., a spacer, etc.) can have various shapes. In some embodiments, the engaging element can have an elongated cylindrical shape with a circular cross-sectional shape. In some embodiments, the engaging element can have an elliptical cross-sectional shape, a crescent-shaped cross-sectional shape, or various other non-cylindrical shapes. The engaging element may have an atrial portion located in or near the left atrium, a ventricular or lower portion located in or near the left ventricle, and a lateral surface extending between the native mitral valve leaflets. In embodiments configured for the tricuspid valve, the atrium or upper portion is located in or near the right atrium, and the ventricle or lower portion is located in or near the right ventricle, and a lateral surface extending between the native tricuspid valve leaflets.
[0194] An anchor can be configured to secure the device to one or two native mitral valve leaflets, such that the conjoint element is positioned between the two native leaflets. In embodiments configured for a tricuspid valve, the anchor is configured to secure the device to one, two, or three tricuspid valve leaflets, such that the conjoint element is positioned between the three native leaflets. In some embodiments, the anchor can be attached to the conjoint element at a location adjacent to the ventricular portion of the conjoint element. In some embodiments, the anchor can be attached to a shaft or actuation wire or other actuating element to which the conjoint element is also attached. In some embodiments, the anchor and the conjoint element can be positioned independently. In some embodiments, the anchor and the conjoint element can be positioned simultaneously. The anchor can be configured to grip the leaflets.
[0195] The prosthetic device can be configured for implantation via a delivery sheath. Additional information on examples of delivery methods can be found in U.S. Patent Application No. 8,449,599 and U.S. Patent Application Publications Nos. 2014 / 0222136, 2014 / 0067052, and 2016 / 0331523, all of which are incorporated herein by reference in their entirety. Furthermore, these methods can be performed on living animals or simulants, such as cadavers, cadaver hearts, simulators (e.g., simulating body parts, hearts, tissues, etc.), with necessary modifications.
[0196] Now for reference Figures 8-14 An example of an implantable prosthetic device 100, schematically illustrated, shows various stages of deployment. However, implantable prosthetic devices can take many different forms as described above. For example, features of this application may be included in any implantable prosthetic device disclosed in U.S. Provisional Patent Application Serial No. 62 / 744,031, Patent Cooperation Treaty Application No. PCT / US2019 / 012707, and / or Patent Cooperation Treaty Application No. PCT / US2018 / 028189. Device 100 may include any other features of the implantable prosthetic devices discussed in this application, and device 100 may be positioned to engage valve tissue (e.g., leaflets 20, 22) as part of any suitable valve repair system (e.g., any valve repair system disclosed in this application).
[0197] Device 100 can be deployed from delivery sheath 102 and may include engagement portion 104 and / or anchoring portion 106. Engagement portion 104 of device 100 includes engagement elements or spacers 110 adapted for implantation between leaflets of a native valve (e.g., native mitral valve, native tricuspid valve, etc.) and slidably attached to an actuating member or actuating element 112 (e.g., wire, shaft, rod, thread, suture, tether, etc.). Anchoring portion 106 is actuable between an open and closed state and can take various forms, such as paddles, latches, snaps, fasteners, gripping elements, etc. Actuation of actuating element 112 (e.g., actuation of an actuating wire, etc.) opens and closes anchoring portion 106 of device 100 to grasp mitral valve leaflets during implantation. Actuating element 112 can take many different forms. For example, the actuating element may be threaded, such that rotation of the actuating element moves anchoring portion 106 relative to engagement portion 104. Alternatively, the actuating element may be threadless, such that pushing or pulling the actuating element 112 moves the anchoring portion 106 relative to the engaging portion 104.
[0198] In some embodiments, the anchoring portion 106 of the device 100 includes an outer blade 120 and an inner blade 122 connected between the cap 114 and the engagement element 110 via portions 124, 126, and 128. Portions 124, 126, and 128 can be coupled, hinged, and / or flexibly movable between all the positions described below. The outer blade 120, inner blade 122, engagement element 110, and cap 114, through the interconnection of portions 124, 126, and 128, can confine the device to the positions and allow movement shown herein. In some embodiments, the device includes only one outer blade 120 and one inner blade 122, and these can be configured in different ways.
[0199] The actuating member or actuating element 112 extends to the cap 114 at the distal connection of the anchoring portion 106 via a delivery sleeve and / or a push tube / rod and / or engaging element or spacer 110. Extending and retracting the actuating element 112 increases and decreases the spacing between the engaging element 110 and the cap 114, respectively. An optional attachment tool or collar (not shown) removably attaches the engaging element 110 to the push tube or rod and / or delivery sleeve 102, such that the actuating element 112 slides along the actuating element 112 during actuation to open and close the blades 120, 122 of the anchoring portion 106. After the device 100 is attached to the valve tissue, if it is necessary to remove the device 100 from the valve tissue, a retrieval device can be used connected to the collar 115, such that the actuating element can extend through the collar 115 and the engaging element 110 to engage the anchoring portion 106, thereby opening the blades 120, 122 and removing the device 100 from the valve tissue. Examples of retrieval devices that may be used are shown in PCT application No. PCT / US2019 / 062391, filed November 20, 2019, which is incorporated herein by reference in its entirety.
[0200] Now for reference Figure 11 The anchoring portion 106 includes an attachment portion or gripping member. The gripping member shown is a barb 130, which includes a base or fixed arm 132, a movable arm 134, a barb 136, and a flexible, hinged, or joint portion 138. However, other friction-enhancing elements may be used instead of the barb. The fixed arm 132 is attached to the inner blade 122, wherein the flexible, hinged, or joint portion 138 is disposed near the engaging element 110. The barb has a flat surface and is not fitted into a recess in the blade. Instead, the flat portion of the barb 130 is disposed against the surface of the inner blade 122. The flexible, hinged, or joint portion 138 provides spring force between the fixed arm 132 and the movable arm 134 of the barb 130. The joint portion 138 may be any suitable flexible portion, hinge, or joint, such as a flexible joint or hinge, a spring joint or hinge, a pivot joint or hinge, etc. In some embodiments, the flexible, hinged, or joint portion 138 is a sheet of flexible material integrally formed with the fixed arm 132 and the movable arm 134. The fixed arm 132 is attached to the inner blade 122 and remains stationary relative to the inner blade 122 when the movable arm 134 is opened to open the barb 130 and expose the barb 136. The barb 130 is opened by applying tension to the actuation line 116 attached to the movable arm 134, thereby allowing the movable arm 134 to move, bend, and / or pivot on the flexible, hinged, or joint portion 138.
[0201] During implantation, blades 120, 122 open and close to capture or hold native mitral leaflets between blades 120, 122 and engagement element 110. Barrel clips 130 further secure the native leaflets by engaging the leaflets with barbs 136 and clamping the leaflets between movable arm 134 and fixed arm 132. The barbs 136 of the clamps 130 increase friction with the leaflets or can partially or completely puncture them. Actuation lines 116 can be actuated independently or individually, allowing each clamp 130 to open and close independently or individually. Individual / independent operation allows for the grasping of one leaflet at a time, or for repositioning the clips 130 onto leaflets that are not fully grasped, without altering the successful grasping of another leaflet. The clamps 130 not only open and close independently of each other, but can also be fully opened and closed independently of the position of the inner blade 122, thus allowing for leaflet capture at various positions as needed.
[0202] The barb 130 can be opened independently or separately by pulling the attached actuation line 116 (or other actuation tool), which extends through the delivery sleeve 102 to the barb 130. The actuation line 116 can take many forms, such as thread, suture, wire, rod, conduit, etc. The barb 130 can be spring-loaded or otherwise biased, so that in the closed position, the barb 130 continues to provide compressive force on the captured or gripped proto-leaflets. This compressive force can remain constant or positive regardless of the position of the inner blade 122. The barbs 136 of the barb 130 can pierce the proto-leaflets to further secure them.
[0203] Now for reference Figure 8 The device 100 is shown in an extended or fully open state for deployment from the delivery sleeve 102. The device 100 is loaded in the fully open position within the delivery sleeve 102 because the fully open position occupies minimal space and allows for the use of the smallest catheter (or the largest implantable device 100 for a given catheter size). In the extended state, the cap 114 is spaced apart from the engagement element 110, such that the blades 120, 122 of the anchoring portion 106 are fully open or fully extended. In some embodiments, the angle formed between the interiors of the outer blade 120 and the inner blade 122 is approximately 180 degrees. The barb 130 remains closed during deployment through the delivery sleeve 102, such that the barb 136 ( Figure 11 It will not get stuck or damage the sheath or tissue in the patient's heart.
[0204] Now for reference Figure 9 The device 100 is displayed as being in an elongated untangled state, similar to... Figure 8However, the barb 130 is in the fully open position, ranging from approximately 140 degrees to approximately 200 degrees, approximately 170 degrees to approximately 190 degrees, or approximately 180 degrees between the fixed and movable portions of the barb 130. Fully opening the paddles 120, 122 and the buckle 130 has been found to improve the ease of untangling from the patient's anatomy during implantation of the device 100.
[0205] Now for reference Figure 10 The device 100 is shown in either a shortened or fully closed state. The compact size of the device 100 in the shortened state allows for easier manipulation and placement within the heart. To move the device 100 from the extended state to the shortened state, the actuating element 112 retracts to pull the cap 114 toward the engaging element 110. The joint, hinge, or flexible connection 126 between the outer blade 120 and the inner blade 122 restricts or constrains movement such that the compressive force acting on the outer blade 120 from the cap 114 retracts toward the engaging element 110, causing the blades 120, 122, or the gripping element to move radially outward. During the movement from the open position to the closed position, the outer blade 120 maintains an acute angle with the actuating element 112. The outer blade 120 may optionally be biased toward the closed position. The inner blades 122 move through a considerable angle during the same movement because they are oriented away from the engaging element 110 in the open state and collapse along the sides of the engaging element 110 in the closed state. In some embodiments, the inner blade 122 is thinner and / or narrower than the outer blade 120, and the joints, hinges, or flexible portions 126, 128 connected to the inner blade 122 may be thinner and / or more flexible. For example, this increased flexibility may allow for more movement compared to the joints, hinges, or flexible portions 124 connecting the outer blade 124 to the cap 114. In some embodiments, the outer blade 120 is narrower than the inner blade 122. The joints or flexible portions 126, 128 connected to the inner blade 122 may be more flexible, for example, to allow for more movement than the joints or flexible portions 124 connecting the outer blade 124 to the cap 114. In some embodiments, the inner blade 122 may have the same or substantially the same width as the outer blade.
[0206] Now for reference Figures 11-13 The device 100 is displayed in a partially open, ready-to-capture, or ready-to-grab state. To transition from a fully closed to a partially open state, the actuating element 112 (e.g., and the actuating wire, actuating shaft, etc.) is extended to push the cap 114 away from the engaging element 110, thereby pulling the outer blade 120, which in turn pulls the inner blade 122, causing the anchoring portion 106 to partially unfold. The actuating wire 116 also retracts to open the latch 130, allowing the leaflet to be captured or grasped. In some embodiments, such as Figure 11In the example shown, a pair of inner blades 122 and outer blades 120 move in unison rather than independently via a single actuating element 112. Furthermore, the position of the latch 130 can depend on the position of the blades 122, 120. For example, refer to... Figure 10 The closed blades 122 and 120 can also close the latch. In some embodiments, blades 120 and 122 can be independently controllable. For example, the device 100 can have two actuating elements and two independent caps, such that one independent wire and cap is used to control one blade, while another independent wire and cap is used to control the other blade.
[0207] Now for reference Figure 12 One of the actuation lines 116 extends to allow one of the latches 130 to close. Now refer to Figure 13 Another actuation line 116 extends to allow another snap 130 to close. Any one or both of the actuation lines 116 can be repeatedly actuated to repeatedly open and close the barbed snap 130.
[0208] Now for reference Figure 14 The device 100 is shown in a fully closed and deployed state. The delivery sleeve 102 and actuation element 112 retract, and the blades 120, 122 and latch 130 remain in the fully closed position. Once deployed, the device 100 can be maintained in the fully closed position by a mechanical latch, or by biasing using a spring material such as steel, other metals, plastics, composites, or a shape memory alloy such as nitinol. For example, the connected, articulated, or flexible portions 124, 126, 128, 138, and / or the inner blade 122 and the outer blade, and / or additional biasing components can be formed of a metal such as steel or a shape memory alloy such as nitinol—produced in wire, sheet, tubing, or laser-sintered powder—and can be biased to keep the outer blade 120 closed around the engagement element or spacer 110 and the hook 130 clamped around the native blade. In some embodiments, the blades 120, 122 may be configured to open and close in response to the heartbeat and the corresponding opening and closing of the native valves.
[0209] Now for reference Figures 15-20 , Figures 8-14 The implantable device 100 is shown as being delivered and implanted within the native mitral valve MV of the heart H. Now refer to Figure 15 The delivery sheath is inserted into the left atrium (LA) through the diaphragm, and the device 100 is deployed from the delivery sheath in the fully open state. The actuator 112 then retracts to move the device 100 to... Figure 16 The fully closed state is shown. (Example) Figure 17 As shown, device 100 moves within the mitral valve MV to a position within the ventricular LV and is partially opened, so that leaflets 20 and 22 can be captured or held. Now refer to Figure 18 The actuation line 116 extends to close a latch 130, thereby capturing the leaflet 20. Figure 19 Another actuation line 116 is shown to then extend to close another latch 130, thereby capturing the remaining leaflet 22. Finally, as... Figure 20 As can be seen, the delivery sheath 102, the actuating element 112, and the actuating line 116 are then retracted and the device 100 is fully closed and deployed in the native mitral valve MV.
[0210] Now for reference Figure 21 , Figures 8-14 The device 100 is shown to be implanted within the native valve in a fully closed position, such as within the native mitral valve MV. The implanted device 100 has an outer blade 120, an inner blade 122, a snap fastener 130, an engagement element 110 (e.g., a spacer, etc.), and a cap 114. The outer blade 120 and the inner blade 122 are connected between the cap 114 and the engagement element 110 via portions 124, 126, 128 (which may be connected and / or flexible to move between different positions). The engagement element 110 is adapted to be implanted between the leaflets 20, 22 of the native valve. The snap fastener 130 is configured to connect the device 100 to the leaflets 20, 22. In some embodiments, the snap fastener 130 includes a retaining arm attached to the inner blade 122 and a movable arm 134 having friction-enhancing elements (e.g., barbs, ridges, rough surfaces, adhesives, etc.) for engaging the leaflets 20, 22 of the native valve. In some embodiments, the device 100 has only one outer blade 120, only one inner blade 122, and only one latch (e.g., barbed latch, etc.), and these can be configured in different ways.
[0211] refer to Figures 22-27 The implantable prosthesis device 100 is attached to the leaflets 20, 22 of the native valve (e.g., illustrated as the mitral valve MV, but can be similarly used for another valve such as the tricuspid valve) in a fully closed position. Figures 22-25 In the illustrated embodiment, the implantable prosthesis 100 is attached to the native valve at approximately the center within the valve annulus 24. However, it should be understood that the implantable prosthesis 100 can be located anywhere within the native valve (e.g., Figures 26-27 The device 100 is attached to leaflets 20 and 22 at the positions shown in the diagram. The device 100 is shown having a pair of blades 120, a pair of snap fasteners 130, an engagement element 110, and a cap 114. However, the implantable prosthesis device 100 can take any suitable form, such as any form described in this application.
[0212] refer to Figure 24 and Figure 25During systole, leaflets 20 and 22 engage around the implantable prosthetic device 100 to prevent blood from flowing back from the left ventricle to the left atrium. However, in some cases, leaflets 20 and 22 may not fully engage around the device 100, which can result in one or more openings or jets 2400 between one or more of the leaflets 20 and 22 and the device 100. Openings 2400 can be formed where both leaflets 20 and 22 meet the device 100. However, openings 2400 can also be formed at any point where the device 100 meets a single leaflet 20 or 22. These openings 2400 allow blood to flow back into the left atrium during systole.
[0213] refer to Figure 26 and Figure 27 The device 100 can be placed within the native valve or mitral valve MV near the annulus 24. This is similar to placing the device 100 in a more central position within the mitral valve MV (e.g.,...). Figure 24 and Figure 25 As shown in the illustration, the opening 2400 can be formed where the two leaflets 20, 22 and the device 100 meet. As illustrated in the embodiment, when the device 100 is placed near the annulus 24, the force exerted by the device 100 on the mitral valve MV may cause portions of the leaflets adjacent to the annulus 24 to converge or wrinkle, and may result in the opening 2400 having a deformed shape. For example, when the device 100 is placed near the annulus, it is more difficult to align the leaflets within the device. When the leaflets are offset from each other within the device 100, portions of the leaflets adjacent to the annulus 24 may converge or wrinkle, and may form an opening 2400 with a deformed shape on one or both sides of the device.
[0214] Figures 28-91Various embodiments of an implantable prosthetic device 100 including one or more leakage control mechanisms or leakage control extensions 2800 are shown, wherein when the heart is in diastole (i.e., blood flows from the atria to the ventricles), the leakage control extension 2800 allows blood to flow through or overflow the leakage control extension 2800, and when the heart is in systole (i.e., blood flows from the ventricles to the atria), the leakage control extension 2800 blocks or deflects at least a portion of the blood flow that would otherwise backflow through the opening 2400. The leakage control extension 2800 can take many different forms. For example, the leakage control extension 2800 can have a substantially flat deflection blade, a curved deflection blade, a pouch or bag opening toward the cap, a deflection blade and fabric assembly, etc. The leakage control extension 2800 can be made of many different materials. For example, the leakage control extension can be made of thin plastic, a wire frame with a fabric cover, a frameless fabric, a fabric with a plastic frame, any combination thereof, etc. The leakage control extension 2800 can be positioned in a variety of different ways. For example, the leakage control extension can be positioned at the base of the native valve leaflet, below the base of the native valve leaflet, between the base of the native valve leaflet and the native valve annulus, or such that a portion of the leakage control extension is located below the native valve leaflet and a portion of the leakage control extension is located between the base of the native valve leaflet and the native valve annulus.
[0215] Figures 28-37 An example of an implantable prosthetic device 100 is shown attached to the leaflets 20, 22 of a native valve in a fully closed position (e.g., illustrated as the mitral valve MV, but similarly applicable to another valve such as the tricuspid valve), wherein the device 100 includes one or more leakage control extensions 2800. Figures 28-35 In the illustrated embodiment, the implantable prosthesis 100 is attached to the native valve at a substantially central location relative to the valve annulus 24. However, it should be understood that the implantable prosthesis 100 can be located anywhere within the native valve (e.g., Figures 36-37 The device 100 is attached to leaflets 20, 22 at the location shown in the diagram. The device 100 has a pair of blades 120, a pair of snap fasteners 130, engaging elements 110 (e.g., spacers, etc.), a cap 114, and a leakage control extension 2800. However, the implantable prosthetic device 100 can take any suitable form, such as any form described herein, and any implantable prosthetic device is disclosed in U.S. Provisional Patent Application Serial No. 62 / 744,031, Patent Cooperation Treaty Application No. PCT / US2019 / 012707, and / or Patent Cooperation Treaty Application No. PCT / US2018 / 028189 in conjunction with the leakage control extension 2800.
[0216] exist Figure 28 and Figure 29In the example shown, the leakage control extension 2800 includes a deflecting blade 2801 attached to the top surface of the cap 14 and positioned below the native valve leaflet. One or more leakage control extensions 2800 are configured to prevent blood from the ventricle from reaching the opening 2400 during systole. That is, one or more leakage control extensions 2800 extend from the device (e.g., from the cap 114 of device 100) such that the leakage control extensions are positioned to prevent blood from moving through any jet or opening between the native valve leaflets 20, 22 during systole. In the illustrated embodiment, the leakage control extension 2800 is positioned in the left ventricle (LV) when device 100 is attached to the leaflets 20, 22. In the illustrated embodiment, device 100 has two leakage control extensions 2800 attached to the top surface of the cap 14. Although the illustrated embodiment is shown with two leakage control extensions 2800, it should be understood that device 100 may have any suitable number of leakage control extensions.
[0217] refer to Figure 30 and Figure 31 During diastole, the leaflets 20 and 22 of the mitral valve MV open, and blood moves from the left atrium LA to the left ventricle LV. Because device 100 is connected to leaflets 20 and 22, when leaflets 20 and 22 are in the open position, a portion 3003 of the mitral valve MV is substantially blocked by device 100, while one or more other portions 3005 of the mitral valve are open, allowing blood to enter the left ventricle LV. Blood moves in direction D through the open portion 3005 and engages the deflection blade 2801 of the leakage control extension 2800. In some embodiments, blood provides a force on the deflection blade 2801 that causes the deflection blade 2801 to pivot about or bend relative to the cap 114, causing blood to move in direction X around the leakage control extension 2800.
[0218] refer to Figures 32-35 During systole, as blood is propelled from the left ventricle into the aorta, the leaflets 20 and 22 of the mitral valve MV engage to prevent backflow of blood into the left atrium LA, and the device 100 is connected to the leaflets 20 and 22 to help facilitate leaflet engagement or occlusion. However, in some cases, the leaflets 20 and 22 may not fully engage around the device 100, which may result in one or more openings or jets 2400 between one or more of the leaflets 20 and 22 and the device 100. The openings 2400 may be formed where both the leaflets 20 and 22 meet the device 100. However, the openings 2400 may also be formed at any point where the device 100 meets a single leaflet 20 or 22. A leakage control extension 2800 is positioned to prevent backflow of blood into the left atrium through one or more openings 2400.
[0219] refer to Figure 32 and Figure 33 Contraction of the left ventricle (LV) propels blood in the Y direction toward the mitral valve (MV) and engages the deflection blades 2801 of the leakage control extension 2800, preventing blood from moving through the opening 2400 and into the left atrium (LA). In some embodiments, blood provides a force on the deflection blades 2801, causing them to pivot about or bend relative to the cap 114, thereby guiding blood in the Z direction away from the opening 2400 around the leakage control extension 2800.
[0220] refer to Figure 36 and Figure 37 , Figures 28-35 The device 100 shown can be placed within the native valve near the annulus 24. This is similar to placing the device 100 in a more central position within the native valve (e.g.,...). Figures 28-35 As shown in the illustration, the opening 2400 can be formed where both leaflets 20 and 22 meet the device 100. As shown in the illustrated embodiment, when the device 100 is placed near the valve annulus 24, the force applied by the device 100 to the native valve can cause the opening 2400 adjacent to the valve annulus 24 to have a deformed shape. In some embodiments, the leakage control extension 2800 is flexible, such that the force applied to the leakage control extension causes the leakage control extension to compress. For example, as... Figure 36 and Figure 37 As shown, the leakage control extension 2800 adjacent to the valve annulus 24 is pressed against the valve annulus 24 (or the lateral wall of the ventricle), causing the leakage control extension 2800 to compress into a deformable shape. This compression of the leakage control extension 2800 allows it to cover the deformable opening 2400 adjacent to the valve annulus 24. The flexible leakage control extension 2800 is advantageous because it allows the device 100 to be positioned at various locations within the native valve without irritating the valve annulus 24 or the lateral wall of the ventricle or atrium. Furthermore, the flexible leakage control extensions 2800 are advantageous because they can take the form of any deformable opening caused by the connection between the device 100 and the leaflets 20, 22.
[0221] Figures 38A-47A An example of an implantable prosthetic device 100 is shown attached to leaflets 20, 22 of a native valve (e.g., illustrated as the mitral valve MV, but which can be similarly used for other valves such as the tricuspid valve) in a fully closed position, wherein the device 100 includes one or more leakage control extensions 2800. Figures 38A-45A In the illustrated embodiment, the implantable prosthesis 100 is attached to the native valve at a substantially central location within the valve annulus 24. However, it should be understood that the implantable prosthesis 100 can be attached at any location within the native valve (e.g., Figures 46A-47AThe device 100 is attached to leaflets 20, 22 at the positions shown. The device 100 has a pair of blades 120, a pair of snap fasteners 130, an engagement element 110 (e.g., a spacer, etc.), a cap 114, and at least one leakage control extension 2800. However, the implantable prosthesis 100 can take any suitable form, such as any form described in this application combined with at least one leakage control extension 2800.
[0222] One or more leakage control extensions 2800 are configured to prevent blood from flowing back from the ventricle into the atrium during systole. That is, one or more leakage control extensions 2800 extend from the device (e.g., from the end of the cap 114 of device 100) such that the leakage control extensions are positioned to prevent blood from moving through any jet or opening between the leaflets 20, 22 of the mitral valve MV during systole. In the illustrated embodiment, the leakage control extension 2800 includes a deflecting blade 2801, which is positioned in the left ventricle (LV) when device 100 is attached to the leaflets 20, 22. In the illustrated embodiment, device 100 has two leakage control extensions 2800 attached to the bottom surface of the cap 114. The leakage control extensions 2800 may be interconnected (as shown in the illustrated embodiment), or the leakage control extensions 2800 may be separate extensions. Although the illustrated embodiment is shown to have two leakage control extensions 2800, it should be understood that the device 100 may have any suitable number of leakage control extensions.
[0223] refer to Figure 40A and Figure 41A During diastole, the leaflets 20 and 22 of the mitral valve MV open, and blood moves from the left atrium LA to the left ventricle LV. Because device 100 is connected to leaflets 20 and 22, when leaflets 20 and 22 are in the open position, a portion 3003 of the mitral valve MV is substantially blocked by device 100, while one or more other portions 3005 of the mitral valve are open, allowing blood to enter the left ventricle LV. Blood moves in direction D through the open portion 3005 and engages the leakage control extension 2800. In some embodiments, blood provides a force on the leakage control extension 2800 that causes the leakage control extension 2800 to pivot about or bend relative to the cap 114, causing blood to move about the leakage control extension 2800 in the X direction.
[0224] refer to Figures 42A-45ADuring systole, as blood is propelled from the left ventricle into the pulmonary artery (PA), the leaflets 20 and 22 of the mitral valve (MV) engage to prevent backflow of blood into the left atrium (LA), and the device 100 is connected to the leaflets 20 and 22 to help facilitate leaflet engagement or apposition. However, in some cases, the leaflets 20 and 22 may not fully engage around the device 100, which may result in one or more openings or jets 2400 between one or more of the leaflets 20 and 22 and the device 100. The openings 2400 may be formed where both the leaflets 20 and 22 meet the device 100. However, the openings 2400 may also be formed at any point where the device 100 meets a single leaflet 20 or 22. A leakage control extension 2800 may be positioned to prevent backflow of blood into the left atrium through one or more openings 2400.
[0225] Reference Figure 42A and Figure 43A Contraction of the left ventricle (LV) propels blood in the Y direction toward the mitral valve (MV) and engages the deflection blades 2801 of the leakage control extension 2800, preventing blood from moving through the opening 2400 and into the left atrium (LA). In some embodiments, blood provides a force on the deflection blades 2801, causing the blades 2801 to pivot about or bend relative to the cap 114, thereby moving blood in the Z direction around the leakage control extension 2800.
[0226] refer to Figure 46A and Figure 47A , Figures 38A-45A The device 100 shown can be placed within the mitral valve MV near the annulus 24. Similarly, the device 100 can be placed more centrally within the mitral valve MV (e.g.,...). Figures 38A-45A As shown in the illustration, opening 2400 can be formed where both leaflets 20 and 22 meet the device 100. As illustrated in the illustrated embodiment, when the device 100 is placed near the annulus 24, the force exerted by the device 100 on the mitral valve MV may cause the opening 2400 adjacent to the annulus 24 to have a deformed shape. In some embodiments, the leakage control extension 2800 is flexible, such that the force applied to the leakage control extension causes the leakage control extension to compress. For example, as... Figure 46A and Figure 47AAs shown, the leakage control extension 2800 adjacent to the valve annulus 24 is pressed against the valve annulus 24 (or the lateral wall of the left ventricle LV), causing the leakage control extension 2800 to compress into a deformed shape. This compression of the leakage control extension 2800 allows it to cover the deformed opening 2400 adjacent to the valve annulus 24. Flexible leakage control extensions 2800 are advantageous because they allow the device 100 to be positioned at various locations within the mitral valve MV. Furthermore, flexible leakage control extensions 2800 are advantageous because they are able to take the form required to prevent blood flow through any deformed openings caused by the connection between the device 100 and the leaflets 20, 22.
[0227] Figure 78 The diagram shows... Figures 38A-47A A more specific example of the implantable prosthesis device 100 shown is provided. Device 100 includes a pair of blades 120, a pair of clips (not shown), engaging elements (e.g., spacers, etc.), a cap 114, and a pair of leakage control extensions 2800. The leakage control extensions 2800 have deflecting blades 2801 comprising a flexible frame 7801 and a barrier material 7803. The flexible frame 7801 may be made of, for example, wire (e.g., steel or nitinol wire, plastic, etc.). The barrier material 7803 may take many different forms. For example, the barrier material may be a fabric material, a biocompatible material, bovine or porcine heart tissue, a plastic membrane, etc. In the illustrated embodiment, the flexible frame 7801 of each leakage control extension 2800 is attached to the front edge 7810 and the rear edge 7812 of the cap 114, and the barrier material 7803 is optionally attached to the side edges 7811, 7813 of the cap 114. This connection between the leak control extension 2800 and the cap 114 allows the leak control extension 2800 to pivot or bend around the side edges 7811, 7813 of the cap.
[0228] Figure 79 The diagram shows... Figures 38A-47A A more specific example of the implantable prosthesis device 100 shown, wherein the leakage control extension 2800 has a... Figure 78Examples of different shapes are shown. For example, the leakage control extension has a narrower shape. Although various example shapes are shown, various different shapes are possible, such as triangular, circular, rectangular, oval, elliptical, etc. In one example embodiment, the shape of the leakage control extension 2800 can be modified by bending before implantation into the device 100. The device 100 includes a pair of blades 120, a pair of snaps (not shown), engaging elements (e.g., spacers, etc.), a cap 114, and a pair of leakage control extensions 2800. The leakage control extension 2800 has deflecting blades 2801 comprising a flexible frame 7901 and a barrier material 7903. The flexible frame 7901 can be made of, for example, wire (e.g., steel or nitinol wire, plastic, etc.). In one example embodiment, the flexible frame is made of a plastically deformable material to allow modification of the shape of the flexible frame 7901 before implantation. The barrier material 7903 can take many different forms. For example, the barrier material can be a fabric material, a biocompatible material, bovine or porcine heart tissue, a plastic film, etc. In the illustrated embodiment, the flexible frame 7901 of each leak control extension 2800 is attached to the front edge 7910 and rear edge 7912 of the cap 114, and the barrier material 7803 is optionally attached to the side edges 7911, 7913 of the cap 114. This connection between the leak control extension 2800 and the cap 114 allows the leak control extension 2800 to pivot or bend around the side edges 7911, 7913 of the cap.
[0229] Figures 38B-47B An example of an implantable prosthetic device 100 is shown attached to the leaflets 20, 22 of a native valve (e.g., illustrated as the mitral valve MV, but which can be similarly used for another valve such as the tricuspid valve) in a fully closed position, wherein the device 100 includes one or more leakage control extensions 2800. Figures 38B-45B In the illustrated embodiment, the implantable prosthesis 100 is attached to the native valve at a substantially central location within the valve annulus 24. However, it should be understood that the implantable prosthesis 100 can be located at any position within the native valve (e.g., Figures 46B-47B Attached to leaflets 20 and 22 at the positions shown in the diagram.
[0230] In some embodiments, the device 100 has a pair of paddles 120, a pair of snaps 130, an engagement element 110 (e.g., a spacer, etc.), a cap 114, and at least one leakage control extension 2800. However, the implantable prosthesis device 100 can take any suitable form, such as any of the forms described in this application in combination with at least one leakage control extension 2800.
[0231] In some embodiments, one or more leakage control extensions 2800 are configured to prevent or inhibit blood backflow from the ventricle into the atrium during systole. That is, one or more leakage control extensions 2800 extend from a device (e.g., from the end of the cap 114 of device 100) such that the leakage control extension is positioned to prevent any jetting or opening of blood through the leaflets 20, 22 of the native valve during systole. In the illustrated embodiment, the leakage control extension 2800 includes a deflecting blade 2801 positioned in the ventricle when device 100 is attached to leaflets 20, 22, wherein the deflecting blade 2801 is attached to spacer 110 via one or more arms 3803.
[0232] In some embodiments, arm 3803 secures deflector blade 2801 to spacer 110 to prevent deflector blade 2801 from moving to a position that does not allow deflector blade 2801 to prevent blood backflow during systole. Arm 3803 may be made of, for example, fabric material, sutures, wires, any combination thereof, or any other suitable material or component capable of securing deflector blade to spacer 110. While the illustrated embodiment shows arm 3803 connecting deflector blade 2801 to spacer 110, it should be understood that arm 3803 may connect deflector blade 2801 to any other part of device 100 that prevents unwanted movement of the deflector blade.
[0233] In the illustrated example, device 100 has two leakage control extensions 2800, each of which includes a deflection blade 2801 attached to the bottom surface of cap 14. The deflection blades 2801 may be interconnected (as shown in the illustrated embodiment), or they may be separate extensions. Although the illustrated embodiment is shown with two leakage control extensions 2800, it should be understood that device 100 may have any suitable number of leakage control extensions.
[0234] refer to Figure 40B and Figure 41B In the example shown, during diastole, the leaflets 20, 22 of the mitral valve MV are open and blood moves from the left atrium LA to the left ventricle LV. Because device 100 is connected to leaflets 20, 22, when leaflets 20, 22 are in the open position, a portion 3003 of the mitral valve MV is substantially blocked by device 100, while one or more other portions 3005 of the mitral valve are open, allowing blood to move into the left ventricle LV. Blood moves in the D direction through the open portion 3005 and engages the leakage control extension 2800. In some embodiments, the blood provides a force on the leakage control extension 2800 that causes the deflecting blade 2801 to pivot about or bend relative to the cap 114, causing blood to move in the X direction around the leakage control extension 2800.
[0235] refer to Figures 42B-45B During systole, the leaflets 20 and 22 of the mitral valve MV engage to prevent backflow of blood into the left atrium LA as blood is pushed from the left ventricle into the pulmonary artery (PA), and the device 100 is connected to the leaflets 20 and 22 to help facilitate leaflet engagement or occlusion. However, in some cases, the leaflets 20 and 22 may not fully engage around the device 100, which may result in one or more openings or jets 2400 between one or more of the leaflets 20 and 22 and the device 100. The openings 2400 may be formed where both the leaflets 20 and 22 meet the device 100. However, the openings 2400 may also be formed at any point where the device 100 meets a single leaflet 20 or 22. A leakage control extension 2800 may be positioned to prevent backflow of blood into the left atrium through one or more openings 2400.
[0236] refer to Figure 42B and Figure 43B Contraction of the left ventricle (LV) propels blood in the Y direction toward the mitral valve (MV) and engages the deflection blades 2801 of the leak control extension 2800, preventing blood from moving through the opening 2400 and into the left atrium (LA). In some embodiments, blood provides a force on the deflection blades 2801, causing them to pivot about or bend relative to the cap 114, thus moving blood in the Z direction around the leak control extension 2800.
[0237] refer to Figure 46B and Figure 47B , Figures 38B-45B The device 100 shown can be placed within the native valve near the annulus 24. This is similar to placing the device 100 in a more central position within the native valve (e.g.,...). Figures 38B-45B As shown in the illustration, opening 2400 can be formed where both leaflets 20 and 22 meet the device 100. As illustrated in the embodiment, when the device 100 is placed near the valve annulus 24, the force exerted by the device 100 on the native valve may cause the opening 2400 adjacent to the valve annulus 24 to have a deformed shape. In some embodiments, the leakage control extension 2800 is flexible, such that the force applied to the leakage control extension causes the leakage control extension to compress. For example, as... Figure 46B and Figure 47BAs shown, the leakage control extension 2800 adjacent to the valve annulus 24 is pressed against the valve annulus 24 (or the side wall of the ventricle), causing the leakage control extension 2800 to compress into a deformable shape. This compression of the leakage control extension 2800 allows it to cover the deformable opening 2400 adjacent to the valve annulus 24. Flexible leakage control extensions 2800 are advantageous because they allow the device 100 to be positioned at various locations within the native valve. Furthermore, flexible leakage control extensions 2800 are advantageous because they are capable of taking the form required to prevent blood flow through any deformable opening caused by the connection between the device 100 and the leaflets 20, 22.
[0238] Figures 48A-57A An example of an implantable prosthetic device 100 is shown attached to the leaflets 20, 22 of a native valve (e.g., illustrated as the mitral valve MV, but which can be similarly used for another valve such as the tricuspid valve) in a fully closed position, wherein the device 100 includes one or more leakage control extensions 2800. Figures 48A-55A In the illustrated embodiment, the implantable prosthesis 100 is attached to the native valve at a substantially central location, wherein the leakage control extension 2800 is between the base of the native valve leaflet and the native valve annulus. However, it should be understood that the implantable prosthesis 100 can be located at any position (e.g., Figures 56A-57A The device 100 is attached to leaflets 20, 22 at the positions shown. The device 100 has a pair of blades 120, a pair of snap fasteners 130, an engagement element 110 (e.g., a spacer, etc.), a cap 114, and at least one leakage control extension 2800. However, the implantable prosthesis 100 can take any suitable form, such as any form described in this application combined with at least one leakage control extension 2800.
[0239] One or more leakage control extensions 2800 are configured to prevent blood from flowing back from the ventricle into the atrium during systole. That is, one or more leakage control extensions 2800 extend from the device such that the leakage control extensions are positioned to prevent blood from moving through the opening between the leaflets 20, 22 of the native valve during systole. In the illustrated embodiment, the leakage control extension 2800 includes a pocket configured to receive blood to prevent blood from moving into the atrium. In some embodiments, the leakage control extension 2800 may have a flexible frame or ring 4801 defining the pocket opening and a barrier material 4803 defining the interior of the pocket. The flexible frame 4801 may have any suitable shape for defining the pocket opening, such as a circle (e.g., circular). Figures 54A-57AThe flexible frame 4801 can be made of, for example, metal wire (e.g., steel or nitinol wire, plastic, etc.). The barrier material 4803 is configured to trap blood, preventing it from moving through the leakage control extension 2800. The barrier material 4803 can be made of, for example, fabric, biocompatible materials, bovine or porcine heart tissue, plastic film, etc.
[0240] In the illustrated embodiment, device 100 has an attachment to a coupling element or spacer 110 (see [link]). Figure 55A The device 100 comprises two leakage control extensions 2800. In some embodiments, when the device 100 is attached to leaflets 20, 22, the openings of the leakage control extensions 2800 are positioned in the atria. However, the leakage control extensions 2800 may be attached to any other part of the device 100, allowing the leakage control extensions 2800 to be positioned to prevent blood backflow into the atria, and the openings of the leakage control extensions 2800 may be in the atria or ventricles. For example, the leakage control extensions 2800 may be attached to a pair of blades 120, a pair of snaps 130, an engagement element 110, a cap 114, or any combination thereof. Although the illustrated embodiment is shown as having two leakage control extensions 2800, it should be understood that the device 100 may have any suitable number of leakage control extensions.
[0241] refer to Figure 50A and Figure 51A During diastole, the leaflets 20 and 22 of the mitral valve MV open, and blood moves from the left atrium LA to the left ventricle LV. Because device 100 is connected to leaflets 20 and 22, when leaflets 20 and 22 are in the open position, a portion 3003 of the mitral valve MV is substantially blocked by device 100, while one or more other portions 3005 of the mitral valve are open, allowing blood to move into the left ventricle LV. Blood moves in the D direction through the open portion 3005 and engages the leakage control extension 2800. In some embodiments, blood exerts a force on the barrier material 4803 of the leakage control extension 2800, causing the barrier material 4803 to compress and causing blood to move in the X direction around the leakage control extension 2800.
[0242] Reference Figures 52A-55ADuring systole, as blood is propelled from the left ventricle into the aorta, the leaflets 20 and 22 of the mitral valve MV engage to prevent backflow of blood into the left atrium LA, and the device 100 is connected to the leaflets 20 and 22 to help facilitate leaflet engagement or occlusion. However, in some cases, the leaflets 20 and 22 may not fully engage around the device 100, which can result in the formation of one or more openings or jets 2400 between one or more of the leaflets 20 and 22 and the device 100. The openings 2400 can be formed where both the leaflets 20 and 22 meet the device 100. However, the openings 2400 can also be formed at any point where the device 100 meets a single leaflet 20 or 22. A leakage control extension 2800 is positioned to prevent backflow of blood into the left atrium through one or more openings 2400.
[0243] refer to Figure 52A and Figure 53A The contraction of the left ventricle (LV) pushes blood in the Y direction toward the mitral valve (MV) and engages the leakage control extension 2800 in the mitral valve. This prevents additional blood from moving through the opening 2400 and into the left atrium (LA). In some embodiments, such as the illustrated embodiment, blood enters the leakage control extension 2800 and provides a force on the barrier material 4803 that causes the barrier material 4803 to expand.
[0244] refer to Figure 56A and Figure 57A , Figures 48A-55A The device 100 shown can be placed within the mitral valve MV near the annulus 24. Similarly, the device 100 can be placed in a more central position within the mitral valve MV (e.g.,...). Figures 48A-55A As shown in the illustration, opening 2400 can be formed where both leaflets 20 and 22 meet the device 100. As illustrated in the illustrated embodiment, when the device 100 is placed near the annulus 24, the force applied by the device 100 to the mitral valve MV can cause the opening 2400 adjacent to the annulus 24 to have a deformed shape. In some embodiments, the flexible frame 4801 of the leakage control extension 2800 is flexible such that the force applied to the leakage control extension 2800 causes the flexible frame 4801 to compress. For example, as... Figure 56A and Figure 57AAs shown, the leakage control extension 2800 adjacent to the valve annulus 24 is pressed against the valve annulus 24 (or the sidewall of the left ventricle LV), causing the flexible frame 4801 to compress into a deformed shape. This compression of the flexible frame 4801 allows the leakage control extension to cover the deformed opening 2400 adjacent to the valve annulus 24. The flexible leakage control extension 2800 is advantageous because it allows the device 100 to be positioned at various locations within the mitral valve MV. Furthermore, the flexible leakage control extensions 2800 are advantageous because they can take the form of any deformed opening caused by the connection between the device 100 and the leaflets 20, 22.
[0245] Figure 80 and Figure 81 The diagram shows... Figures 48A-57A A more specific example of the implantable prosthesis device 100 shown is provided. Device 100 includes a pair of paddles 120, a pair of snaps (not shown), engaging elements (e.g., spacers, etc.), a cap 114, and a pair of leakage control extensions 2800. The leakage control extensions 2800 have a flexible frame 4801 defining a pocket opening 8005 and a barrier material 4803 defining the interior of the pocket. In the illustrated embodiment, the flexible frame 4801 is formed to give the opening 8005 a circular shape. The barrier material 4803 is configured to trap blood, preventing blood from moving through the leakage control extensions 2800.
[0246] Figures 48B-57B An example implantable prosthetic device 100 is shown attached to leaflets 20, 22 of a native valve (e.g., illustrated as the mitral valve MV, but which could be similarly used for another valve such as the tricuspid valve) in a fully closed position, wherein the device 100 includes one or more leakage control extensions 2800. Figures 48B-55B In the illustrated embodiment, the implantable prosthesis 100 is attached to the native valve at a substantially central location, with the leakage control extension 2800 located between the base of the native valve leaflet and the native valve annulus. However, it should be understood that the implantable prosthesis 100 can be located at any position (e.g., Figures 56B-57B The device 100 is attached to leaflets 20, 22 at the positions shown. The device 100 has a pair of blades 120, a pair of snap fasteners 130, an engagement element 110 (e.g., a spacer, etc.), a cap 114, and at least one leakage control extension 2800. However, the implantable prosthesis 100 can take any suitable form, such as any form described in this application combined with at least one leakage control extension 2800.
[0247] One or more leakage control extensions 2800 are configured to prevent blood from flowing back from the ventricle into the atrium during systole. That is, one or more leakage control extensions 2800 extend from the device such that the leakage control extensions are positioned to prevent blood movement through the opening between the leaflets 20, 22 of the native valve during systole. In the illustrated embodiment, the leakage control extension 2800 is a pocket configured to receive blood to prevent blood from moving into the atrium. In some embodiments, the leakage control extension 2800 may have a flexible frame or ring 4801 defining the pocket opening and a barrier material 4803 defining the interior of the pocket. The flexible frame 4801 may have any suitable shape for defining the pocket opening, such as a circle (e.g., circular). Figures 54B-57B The flexible frame 4801 can be made of, for example, metal wire (e.g., steel or nitinol wire, plastic, etc.). The barrier material 4803 is configured to trap blood, preventing it from moving through the leakage control extension 2800. The barrier material 4803 can be made of, for example, fabric, biocompatible materials, bovine or porcine heart tissue, plastic film, etc.
[0248] In the illustrated embodiment, device 100 has an attachment to a coupling element or spacer 110 (see [link]). Figure 55B The device 100 comprises two leakage control mechanisms or leakage control extensions 2800. In the illustrated embodiment, when the device 100 is attached to leaflets 20, 22, a portion of the leakage control extension 2800 is in the atrium and another portion of the leakage control extension 2800 is in the ventricle, such that the opening of the leakage control extension 2800 is positioned in the ventricle. However, the leakage control extension 2800 may be attached to any other portion of the device 100 that allows the leakage control extension 2800 to be positioned to prevent blood backflow into the atrium, and the opening of the leakage control extension 2800 may be in the atrium or ventricle. For example, the leakage control extension 2800 may be attached to a pair of blades 120, a pair of snaps 130, an engagement element 110, a cap 114, or any combination thereof. Although the illustrated embodiment is shown as having two leakage control extensions 2800, it should be understood that the device 100 may have any suitable number of leakage control extensions.
[0249] refer to Figure 50B and Figure 51BDuring diastole, the leaflets 20 and 22 of the mitral valve MV open, and blood moves from the left atrium LA to the left ventricle LV. Because device 100 is connected to leaflets 20 and 22, when leaflets 20 and 22 are in the open position, a portion 3003 of the mitral valve MV is substantially blocked by device 100, while one or more other portions 3005 of the mitral valve are open, allowing blood to move into the left ventricle LV. Blood moves in the D direction through the open portion 3005 and engages the leakage control extension 2800. In some embodiments, blood exerts a force on the barrier material 4803 of the leakage control extension 2800, causing the barrier material 4803 to compress and causing blood to move in the X direction around the leakage control extension 2800.
[0250] refer to Figures 52B-55B During systole, as blood is propelled from the left ventricle (LV) into the aorta, the leaflets 20 and 22 of the mitral valve (MV) engage to prevent backflow of blood into the left atrium (LA), and the device 100 is connected to the leaflets 20 and 22 to help facilitate leaflet engagement or occlusion. However, in some cases, the leaflets 20 and 22 may not fully engage around the device 100, which can result in the formation of one or more openings or jets 2400 between one or more of the leaflets 20 and 22 and the device 100. The openings 2400 can be formed where both the leaflets 20 and 22 meet the device 100. However, the openings 2400 can also be formed at any point where the device 100 meets a single leaflet 20 or 22. A leakage control extension 2800 is positioned to prevent backflow of blood into the left atrium through one or more openings 2400.
[0251] refer to Figure 52B and Figure 53B The contraction of the left ventricle (LV) pushes blood in the Y direction toward the mitral valve (MV) and engages the leakage control extension 2800 in the mitral valve. This prevents additional blood from moving through the opening 2400 and into the left atrium (LA). In some embodiments, such as the illustrated embodiment, blood enters the leakage control extension 2800 and provides a force on the barrier material 4803 that causes the barrier material 4803 to expand.
[0252] refer to Figure 56B and Figure 57B , Figures 48B-55B The device 100 shown can be placed within the native valve near the annulus 24. This is similar to placing the device 100 in a more central position within the native valve (e.g.,...). Figures 54B-55BAs shown in the illustration, opening 2400 can be formed where both leaflets 20 and 22 meet the device 100. As illustrated in the illustrated embodiment, when the device 100 is placed near the valve annulus 24, the force applied by the device 100 to the native valve can cause the opening 2400 adjacent to the valve annulus 24 to have a deformed shape. In some embodiments, the flexible frame 4801 of the leakage control extension 2800 is flexible such that the force applied to the leakage control extension 2800 causes the flexible frame 4801 to compress. For example, as... Figure 56B and Figure 57B As shown, the leakage control extension 2800 adjacent to the valve annulus 24 is pressed against the valve annulus 24 (or the sidewall of the ventricle), causing the flexible frame 4801 to compress into a deformable shape. This compression of the flexible frame 4801 allows the leakage control extension to cover the deformable opening 2400 adjacent to the valve annulus 24. The flexible leakage control extension 2800 is advantageous because it allows the device 100 to be positioned at various locations within the native valve. Furthermore, the flexible leakage control extensions 2800 are advantageous because they can take the form of any deformable opening caused by the connection between the device 100 and the native leaflet.
[0253] Figures 58-67 An example of an implantable prosthetic device 100 attached to leaflets 20, 22 of a native valve (e.g., illustrated as the mitral valve MV, but which can be similarly used for another valve such as the tricuspid valve) is shown. Figures 58-65 In the illustrated embodiment, the implantable prosthesis 100 is attached to the native valve at a substantially central location on the valve leaflet. However, it should be understood that the implantable prosthesis 100 can be located at any position (e.g., Figures 56A-57A (As shown in the image) is attached to leaflets 20 and 22. Figures 58-67 In the example shown, the leakage control extension 2800 is positioned between the end of the native valve leaflet and the native valve annulus. The device 100 has a pair of blades 120, a pair of snaps 130, an engagement element 110 (e.g., a spacer, etc.), a cap 114, and at least one leakage control extension 2800. However, the implantable prosthetic device 100 can take any suitable form, such as any of the forms described in this application combined with at least one leakage control extension 2800.
[0254] One or more leakage control extensions 2800 are configured to prevent blood from flowing back from the ventricles into the atria during systole. Figures 58-67 In the example shown, one or more leakage control extensions 2800 extend from the device such that the leakage control extensions are positioned to prevent blood from flowing through the opening between the leaflets 20, 22 of the native valve during systole. In the illustrated embodiment, the leakage control extension 2800 is a pocket configured to receive blood to block blood moving toward the atrium in the native valve.
[0255] In some embodiments, the leakage control extension 2800 may have a flexible frame or ring 4801 defining a pocket opening and a barrier material 4803 defining the interior of the pocket. The flexible frame 4801 may have any suitable shape for defining the pocket opening, such as a circle (e.g., circular). Figures 64-67 (As shown), elliptical, triangular, polygonal, etc. The flexible frame 4801 can be made of, for example, metal wire, such as steel or nitinol wire, plastic, etc. The barrier material 4803 is configured to trap blood, preventing blood from moving through the leakage control extension 2800. The barrier material 4803 can be made of, for example, cloth material, biocompatible material, bovine or porcine heart tissue, plastic film, etc.
[0256] In the illustrated embodiment, device 100 has two leakage control extensions 2800 attached to the top of device 100 to a coupling element or spacer 110. In some embodiments, when device 100 is attached to leaflets 20, 22, the openings of the leakage control extensions 2800 are located approximately midway between the progenitor valve annulus and the progenitor valve leaflet tip. The leakage control extensions 2800 may be attached to device 100 to allow the leakage control extensions 2800 to be positioned to prevent all or part of the blood from flowing back into any other part of the atrium, and the openings of the leakage control extensions 2800 may be in the atrium or ventricle. For example, the leakage control extensions 2800 may be attached to a pair of blades 120, a pair of snaps 130, a coupling element 110, a cap 114, or any combination thereof. Furthermore, the leakage control extensions 2800 may be positioned at any location along the height of device 100. Although the illustrated embodiment is shown as having two leakage control extensions 2800, it should be understood that device 100 may have any suitable number of leakage control extensions.
[0257] refer to Figure 60 and Figure 61 During diastole, the leaflets 20 and 22 of the native valve (shown as the mitral valve MV) open, and blood moves from the left atrium (LA) to the left ventricle (LV). Because device 100 is connected to leaflets 20 and 22, when leaflets 20 and 22 are in the open position, a portion 3003 of the mitral valve MV is substantially blocked by device 100, while one or more other portions 3005 of the mitral valve are open, allowing blood to move into the left ventricle (LV). Blood moves in the D direction through the open portion 3005 and engages the leakage control extension 2800. In some embodiments, blood applies a force to the barrier material 4803 of the leakage control extension 2800, causing the barrier material 4803 to compress and causing blood to move in the X direction around the leakage control extension 2800.
[0258] refer to Figures 62-65During systole, as blood is propelled from the left ventricle into the pulmonary artery (PA), the leaflets 20 and 22 of the mitral valve (MV) engage to prevent backflow into the left atrium (LA), and the device 100 is connected to the leaflets 20 and 22 to help facilitate leaflet engagement or occlusion. However, in some cases, the leaflets 20 and 22 may not fully engage around the device 100, which can result in one or more openings or jets 2400 between one or more of the leaflets 20 and 22 and the device 100. The openings 2400 can be formed where both the leaflets 20 and 22 meet the device 100. However, the openings 2400 can also be formed at any point where the device 100 meets a single leaflet 20 or 22. A leakage control extension 2800 is positioned to prevent backflow of blood through one or more openings 2400 into the left atrium.
[0259] refer to Figure 62 and Figure 63 Contraction of the left ventricle (LV) propels blood along the Y direction toward the mitral valve (MV), through opening 2400, and engages with leakage control extension 2800. This engagement with leakage control extension 2800 prevents blood flowing through opening 2400 from flowing into the left atrium (LA). In some embodiments, such as the illustrated embodiment, blood enters leakage control extension 2800 and provides a force on barrier material 4803 that causes barrier material 4803 to expand.
[0260] refer to Figure 66 and Figure 67 , Figures 58-65 The device 100 shown can be placed within the native valve near the annulus 24. This is similar to placing the device 100 in a more central position within the native valve (e.g.,...). Figures 58-65 As shown in the illustration, opening 2400 can be formed where both leaflets 20 and 22 meet the device 100. As illustrated in the embodiment, when the device 100 is placed near the annulus 24, the force applied by the device 100 to the native valve can cause the opening 2400 adjacent to the annulus 24 to have a deformed shape. In some embodiments, the flexible frame 4801 of the leakage control extension 2800 is flexible such that the force applied to the leakage control extension 2800 causes the flexible frame 4801 to compress. For example, as... Figure 66 and Figure 67As shown, the leakage control extension 2800 adjacent to the valve annulus 24 is pressed against the valve annulus 24 (or the lateral wall of the ventricle), causing the flexible frame 4801 to compress into a deformable shape. This compression of the flexible frame 4801 allows the leakage control extension to cover the deformable opening 2400 adjacent to the valve annulus 24. The flexible leakage control extensions 2800 are advantageous because they allow the device 100 to be positioned at various locations within the native valve without irritating the valve annulus 24 or the lateral wall of the ventricle or atrium. Furthermore, the flexible leakage control extensions 2800 are advantageous because they can take the form of preventing flow through any deformable opening caused by the connection between the device 100 and the leaflets 20, 22.
[0261] Figures 68-77 An example of an implantable prosthetic device 100 is shown attached to leaflets 20, 22 of a native valve (e.g., illustrated as the mitral valve MV, but similarly applicable to another valve such as the tricuspid valve) in a fully closed position. Figures 68-75 In the illustrated embodiment, the implantable prosthesis 100 is attached to the native valve at a substantially central location within the valve annulus 24. However, it should be understood that the implantable prosthesis 100 can be located anywhere within the native valve (e.g., Figures 66-67 The device 100 is attached to leaflets 20, 22 at the location shown in the diagram. The device 100 has a pair of blades 120, a pair of snap fasteners 130, an engagement element 110 (e.g., a spacer, etc.), a cap 114, and at least one leakage control extension 2800. However, the implantable prosthesis 100 can take any suitable form, such as any form described in this application combined with at least one leakage control extension 2800.
[0262] One or more leakage control extensions 2800 are configured to prevent blood from flowing back from the ventricles into the atria during systole. That is, one or more leakage control extensions 2800 extend from the device such that they are positioned to prevent blood from moving through any jet or opening between the leaflets 20, 22 of the native valve during systole. In the illustrated embodiment, the leakage control extension 2800 is a pocket configured to receive blood to prevent it from moving into the atria. In some embodiments, the leakage control extension 2800 has a flexible frame 4801 defining a pocket opening and a barrier material 4803 defining the interior of the pocket.
[0263] The flexible frame 4801 can have any suitable shape for defining the pocket opening, such as a circle (e.g.) Figures 74-77The flexible frame 4801 can be made of, for example, metal wire such as steel or nitinol wire, plastic, etc. The barrier material 4803 is configured to trap blood, preventing it from moving through the leak control extension 2800. The barrier material 4803 can be made of, for example, fabric, biocompatible material, bovine or porcine heart tissue, plastic film, etc. In the illustrated embodiment, the device 100 has two leak control extensions 2800 attached to the cap 114.
[0264] In some embodiments, when the device 100 is attached to leaflets 20, 22, the opening of the leakage control extension 2800 is positioned in the ventricle. The leakage control extension 2800 may be attached to any other part of the device 100, allowing the leakage control extension 2800 to be positioned to prevent blood backflow into the atrium, and the opening of the leakage control extension 2800 may be in the atrium or ventricle. For example, the leakage control extension 2800 may be attached to a pair of blades 120, a pair of snaps 130, an engagement element 110, a cap 114, or any combination thereof. Furthermore, the leakage control extension 2800 may be positioned at any location along the height of the device 100. Although the illustrated embodiment is shown as having two leakage control extensions 2800, it should be understood that the device 100 may have any suitable number of leakage control extensions.
[0265] refer to Figure 70 and Figure 71 During diastole, the leaflets 20 and 22 of the native valve (illustrated as the mitral valve MV) open, and blood moves from the left atrium LA to the left ventricle LV. Because device 100 is connected to leaflets 20 and 22, when leaflets 20 and 22 are in the open position, a portion 3003 of the mitral valve MV is substantially blocked by device 100, while one or more other portions 3005 of the mitral valve are open, allowing blood to enter the left ventricle LV. Blood moves in the D direction through the open portion 3005 and engages the leakage control extension 2800. In some embodiments, blood exerts a force on the barrier material 4803 of the leakage control extension 2800, causing the barrier material 4803 to compress and causing blood to move in the X direction around the leakage control extension 2800.
[0266] refer to Figures 72-75During systole, as blood is propelled from the left ventricle into the pulmonary artery (PA), the leaflets 20 and 22 of the mitral valve (MV) engage to prevent backflow of blood into the left atrium (LA), and the device 100 is connected to the leaflets 20 and 22 to help facilitate leaflet engagement or apposition. However, in some cases, the leaflets 20 and 22 may not fully engage around the device 100, which can result in the formation of one or more openings or jets 2400 between one or more of the leaflets 20 and 22 and the device 100. The openings 2400 can be formed where both the leaflets 20 and 22 meet the device 100. However, the openings 2400 can also be formed at any point where the device 100 meets a single leaflet 20 or 22. A leakage control extension 2800 is positioned to prevent backflow of blood into the left atrium through one or more openings 2400.
[0267] Reference Figure 72 and Figure 73 The contraction of the left ventricle (LV) pushes blood in the Y direction toward the mitral valve (MV) and engages the leakage control extension 2800, preventing blood from moving through the opening 2400 and into the left atrium (LA). In some embodiments, such as the illustrated embodiment, blood enters the leakage control extension 2800 and provides a force on the barrier material 4803 that causes the barrier material 4803 to expand.
[0268] refer to Figure 76 and Figure 77 , Figures 68-75 The device 100 shown can be placed within the native valve near the annulus 24. This is similar to placing the device 100 in a more central position within the native valve (e.g.,...). Figures 68-75 As shown in the illustration, the opening 2400 can be formed where both leaflets 20 and 22 meet the device 100. As shown in the illustrated embodiment, when the device 100 is placed near the valve annulus 24, the force applied by the device 100 to the native valve can cause the opening 2400 adjacent to the valve annulus 24 to have a deformed shape.
[0269] In some embodiments, the flexible frame 4801 of the leak control extension 2800 is flexible, such that forces applied to the leak control extension 2800 cause the flexible frame 4801 to compress or deform. For example, as Figure 76 and Figure 77As shown, the leakage control extension 2800 adjacent to the valve annulus 24 is pressed against the valve annulus 24 (or the lateral wall of the ventricle), causing the flexible frame 4801 to compress into a deformable shape. This compression of the flexible frame 4801 allows the leakage control extension to cover the deformable opening 2400 adjacent to the valve annulus 24. The flexible leakage control extension 2800 is advantageous because it allows the device 100 to be positioned at various locations within the native valve without irritating the valve annulus 24 or the lateral wall of the left ventricle or atrium. Furthermore, the flexible leakage control extensions 2800 are advantageous because they can take the form of any deformable opening caused by the connection between the device 100 and the leaflets 20, 22.
[0270] Figures 82-91 An example of an implantable prosthetic device 100 is shown attached to leaflets 20, 22 of a native valve (e.g., shown as the mitral valve MV, but which can be similarly used on another valve such as the tricuspid valve) in a fully closed position, wherein the device 100 includes one or more leakage control extensions 2800. Figures 82-89 In the illustrated embodiment, the implantable prosthesis 100 is attached to the native valve at a substantially central location within the valve annulus 24. However, it should be understood that the implantable prosthesis 100 can be located at any position within the native valve (e.g., Figures 90-91 The device 100 is attached to leaflets 20, 22 at the location shown in the diagram. The device 100 has a pair of blades 120, a pair of snap fasteners 130, an engagement element 110 (e.g., a spacer, etc.), a cap 114, and at least one leakage control extension 2800. However, the implantable prosthesis 100 can take any suitable form, such as any form described in this application combined with at least one leakage control extension 2800.
[0271] One or more leakage control extensions 2800 are configured to prevent blood from flowing back from the ventricles into the atria during systole. Specifically, one or more leakage control extensions 2800 extend from a device (e.g., from the end of the cap 114 of device 100) such that the leakage control extensions are positioned to prevent blood movement through any jet or opening between the leaflets 20, 22 of the native valve. Each leakage control extension 2800 may include one or more deflecting blades 2801 (or other extension members) and a barrier element 8203. One or more deflecting blades 2801 may be attached to the cap 114 of device 100 (or any other part of device 100), and the barrier element 8203 may be attached to blade 120 and deflecting blades 2801 to form a barrier extending from the first blade 120 of device 100 to the second blade of device 100, wherein the barrier prevents blood backflow during systole. In the illustrated embodiment, each leakage control extension 2800 includes two deflection blades 2801 attached to the cap 114 and a barrier element 8203 connected to and extending from the first blade 120, the two deflection blades 2801, and to the other blade 120. The barrier element 8203 may comprise one or more pieces of material, such as one or more pieces of fabric, biocompatible material, bovine or porcine heart tissue, plastic film, etc. In the illustrated embodiment, the device 100 has two leakage control extensions 2800, each of which includes one or more deflection blades 2801 and barrier material 8203. Although the illustrated embodiment is shown with two leakage control extensions 2800, it should be understood that the device 100 may have any suitable number of leakage control extensions.
[0272] refer to Figure 84 and Figure 85 During diastole, the leaflets 20 and 22 of the mitral valve MV open, and blood moves from the left atrium LA to the left ventricle LV. Because device 100 is connected to leaflets 20 and 22, when leaflets 20 and 22 are in the open position, a portion 3003 of the mitral valve MV is substantially blocked by device 100, while one or more other portions 3005 of the mitral valve are open, allowing blood to move into the left ventricle LV. Blood moves in the D direction through the open portion 3005 and engages the leakage control extension 2800. In some embodiments, blood provides a force on the leakage control extension 2800 that causes the deflecting blade 2801 to pivot about or bend relative to the cap 114, causing blood to move in the X direction around the leakage control extension 2800.
[0273] refer to Figures 86-89During systole, as blood is propelled from the left ventricle into the pulmonary artery (PA), the leaflets 20 and 22 of the mitral valve (MV) engage to prevent backflow of blood into the left atrium (LA), and the device 100 is connected to the leaflets 20 and 22 to help facilitate leaflet engagement or apposition. However, in some cases, the leaflets 20 and 22 may not fully engage around the device 100, which can result in the formation of one or more openings or jets 2400 between one or more of the leaflets 20 and 22 and the device 100. The openings 2400 can be formed where both the leaflets 20 and 22 meet the device 100. However, the openings 2400 can also be formed at any point where the device 100 meets a single leaflet 20 or 22. A leakage control extension 2800 can be positioned to prevent backflow of blood into the left atrium through one or more openings 2400.
[0274] refer to Figure 86 and Figure 87 Contraction of the left ventricle (LV) propels blood in the Y direction toward the mitral valve (MV) and engages the deflection blades 2801 and barrier element 8203 of the leakage control extension 2800, preventing blood from flowing through the opening 2400 and into the left atrium (LA). In some embodiments, blood provides a force on the deflection blades 2801, causing them to pivot or bend relative to the cap 114, thus moving blood in the Z direction around the leakage control extension 2800. In some embodiments, blood provides a force on the barrier element 8203, causing a portion of the barrier element 8203 located between the two deflection blades 2801 to move in an upward direction.
[0275] refer to Figure 90 and Figure 91 , Figures 82-89 The device 100 shown can be placed within the native valve near the annulus 24. This is similar to placing the device 100 in a more central position within the native valve (e.g.,...). Figures 82-89 As shown in the illustration, opening 2400 can be formed where both leaflets 20 and 22 meet the device 100. As illustrated in the illustrated embodiment, when the device 100 is placed near the valve annulus 24, the force exerted by the device 100 on the native valve can cause the opening 2400 adjacent to the valve annulus 24 to have a deformed shape. In some embodiments, the leakage control extension 2800 is flexible, such that the force applied to the leakage control extension causes the leakage control extension to compress. For example, as... Figure 90 and Figure 91As shown, the leakage control extension 2800 adjacent to the valve annulus 24 is pressed against the valve annulus 24 (or the side wall of the ventricle), causing the leakage control extension 2800 to compress into a deformable shape. This compression of the leakage control extension 2800 allows it to cover the deformable opening 2400 adjacent to the valve annulus 24. Flexible leakage control extensions 2800 are advantageous because they allow the device 100 to be positioned at various locations within the native valve. Furthermore, flexible leakage control extensions 2800 are advantageous because they are capable of taking the form required to prevent blood flow through any deformable opening caused by the connection between the device 100 and the leaflets 20, 22.
[0276] While various inventive aspects, concepts, and features of this disclosure may be described and illustrated herein as being embodied in combination in exemplary embodiments, these various aspects, concepts, and features may be used individually or in various combinations and sub-combinations in many alternative embodiments. Unless expressly excluded herein, all such combinations and sub-combinations are intended to fall within the scope of this application. Furthermore, while various alternative embodiments of various aspects, concepts, and features of this disclosure—such as alternative materials, structures, configurations, methods, apparatuses and components, alternatives in form, assembly, and function, etc.—may be described herein, such description is not intended to be a complete or exhaustive list of available alternative embodiments, whether currently known or developed hereafter. Those skilled in the art will readily adopt one or more inventive aspects, concepts, or features into additional embodiments and uses within the scope of this application, even if such embodiments are not expressly disclosed herein.
[0277] Furthermore, even if some features, concepts, or aspects of this disclosure may be described herein as preferred arrangements or methods, such description is not intended to imply that such features are needed or required unless explicitly stated otherwise. Moreover, exemplary or representative values and ranges may be included to aid in understanding this application; however, these values and ranges should not be construed as restrictive and are intended to be critical values or ranges only if explicitly stated otherwise.
[0278] Furthermore, while various aspects, features, and concepts may be expressly identified herein as having inventive step or forming part of the disclosure, such identification is not intended to be exclusive, but rather may exist where there are inventive aspects, concepts, and features fully described herein, but not expressly identified as inventive aspects, features, and concepts or forming part of this disclosure, which are instead set forth in the appended claims. The description of exemplary methods or processes is not limited to including all steps necessary in all cases, and the order in which steps are presented is not to be construed as necessary or required unless expressly stated otherwise. Furthermore, the techniques, methods, operations, steps, etc., described or suggested herein can be performed on living animals or non-living simulations, such as on a cadaver, a cadaver's heart, a simulator (e.g., simulated body parts, tissues, etc.). The words used in the claims have their full ordinary meaning and are not limited in any way by the description of the embodiments in the specification.
Claims
1. A valve repair device for repairing a patient's native valve, the valve repair device comprising: Spacers; A pair of blades coupled to the spacer, wherein the pair of blades is movable between an open position and a closed position, wherein the pair of blades is configured to attach the valve repair device to the patient’s original valve; At least one deflecting leak control extension extending from the spacer, wherein the leak control extension is configured to block retrograde blood flow from the ventricle to the atrium along the side of the spacer during the heart's systolic phase, and is configured to allow blood to flow from the atrium to the ventricle through the leak control extension during the heart's diastolic phase. The at least one deflecting leak control extension is configured to bend toward the ventricle of the heart during diastole; The at least one deflecting leak control extension is configured to bend toward the atrium of the heart during systole; and The at least one deflection-type leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the original valve when the valve repair device is attached to the original valve.
2. The valve repair device according to claim 1, further comprising a cap connected to the spacer.
3. The valve repair device of claim 2, wherein the at least one deflection-type leakage control extension is connected to the cap, and the cap is connected to the spacer.
4. The valve repair device of claim 2, wherein the at least one deflecting leak control extension is pivotally attached to the cap.
5. The valve repair device according to any one of claims 1-4, further comprising a pair of clips, wherein the pair of blades and the pair of clips are configured to attach the valve repair device to the patient's native valve.
6. The valve repair device according to any one of claims 1-5, wherein the spacer is configured to close the gap in the patient's native valve when the valve repair device is attached to the native valve.
7. The valve repair device according to any one of claims 1-6, wherein the at least one deflecting leakage control extension includes a deflector blade having a flexible wireframe covered by a cloth barrier material.
8. The valve repair apparatus of claim 7, wherein the deflector blades are connected to the spacer via one or more arms.
9. The valve repair device of claim 7, wherein the flexible wireframe is configured to deform when positioned against the wall of the patient's heart.
10. The valve repair device according to any one of claims 1-6, wherein the at least one deflector leakage control extension comprises one or more deflector blades and a barrier element.
11. The valve repair device of claim 10, wherein each of the one or more deflector blades has a flexible wireframe covered by a fabric barrier material.
12. The valve repair device according to any one of claims 10-11, wherein the barrier element comprises at least one of a cloth material, a biocompatible material, bovine or porcine heart tissue, and a plastic membrane.
13. A valve repair device for repairing a native valve, the valve repair device comprising: At least one anchor, the at least one anchor being configured to attach the valve repair device to the patient's native valve; as well as At least one deflection leakage control extension extends from a portion of the device, wherein the deflection leakage control extension is configured to block retrograde blood flow from the ventricle to the atrium near or adjacent to the device during the heart's systolic phase, and is configured to allow blood to flow from the atrium to the ventricle through the deflection leakage control extension during the heart's diastolic phase. The at least one deflecting leak control extension is configured to bend toward the ventricle of the heart during diastole; The at least one deflecting leak control extension is configured to bend toward the atrium of the heart during systole; and The at least one deflection-type leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the original valve when the valve repair device is attached to the original valve.
14. The valve repair device according to claim 13 further includes a coupling element.
15. The valve repair device of claim 14, wherein the at least one deflecting leakage control extension extends from the coupling element and is configured to block retrograde blood flow along the side of the coupling element.
16. The valve repair device according to any one of claims 14-15, further comprising a cap connected to the engagement element.
17. The valve repair device of claim 16, wherein the at least one deflection-type leakage control extension is connected to the cap, and the cap is connected to the engagement element.
18. The valve repair device according to any one of claims 16-17, wherein the at least one deflecting leak control extension is pivotally attached to the cap.
19. The valve repair device according to any one of claims 14-18, wherein the at least one anchor comprises a pair of blades coupled to the engagement element.
20. The valve repair device according to any one of claims 14-19, wherein the engaging element is configured to close the gap in the patient's native valve when the valve repair device is attached to the native valve.
21. The valve repair device according to any one of claims 13-20, further comprising at least one snap fastener, wherein the at least one anchor and the at least one snap fastener are configured to attach the valve repair device to the patient's native valve.
22. The valve repair device of claim 21, wherein at least one snap-fit is coupled to the cap of the device.
23. The valve repair device according to any one of claims 14-20, wherein the at least one deflecting leakage control extension includes a deflector blade having a flexible wireframe covered by a cloth barrier material.
24. The valve repair apparatus of claim 23, wherein the deflector blades are connected to the engagement element via one or more arms.
25. The valve repair device of claim 23, wherein the flexible wireframe is configured to deform when positioned against the wall within the patient's native valve.
26. The valve repair device according to any one of claims 13-22, wherein the at least one deflector leakage control extension comprises one or more deflector blades and a barrier element.
27. The valve repair device of claim 26, wherein each of the one or more deflector blades has a flexible wireframe covered by a fabric barrier material.
28. The valve repair device according to any one of claims 26-27, wherein the barrier element comprises at least one of a cloth material, a biocompatible material, bovine or porcine heart tissue, and a plastic membrane.
29. A valve repair system for repairing a patient's native valve, the valve repair system comprising: Conveyor sleeve; A valve repair device capable of being deployed to the patient's native valve via the delivery sheath; The valve repair device includes: Spacers; A pair of blades coupled to the spacer, wherein the pair of blades is movable between an open position and a closed position, wherein the pair of blades is configured to attach the valve repair device to the patient’s original valve; At least one deflecting leakage control extension extending from the spacer, wherein the deflecting leakage control extension is configured to block retrograde blood flow from the ventricle to the atrium along the side of the spacer during the heart's systolic phase, and is configured to allow blood to flow from the atrium to the ventricle through the deflecting leakage control extension during the heart's diastolic phase. The at least one deflecting leak control extension is configured to bend toward the ventricle of the heart during diastole; The at least one deflecting leak control extension is configured to bend toward the atrium of the heart during systole; and The at least one deflection-type leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the original valve when the valve repair device is attached to the original valve.
30. The system of claim 29, further comprising a cap connected to the spacer.
31. The system of claim 30, wherein the at least one deflecting leak control extension is connected to the cap, and the cap is connected to the spacer.
32. The system of claim 30, wherein the at least one deflecting leak control extension is pivotally attached to the cap.
33. The system according to any one of claims 29-32 further includes a pair of clips, wherein the pair of blades and the pair of clips are configured to attach the valve repair device to the patient's original valve.
34. The system according to any one of claims 29-33, wherein the spacer is configured to close the gap in the patient's native valve when the valve repair device is attached to the native valve.
35. The system according to any one of claims 29-34, wherein the at least one deflecting leakage control extension includes a deflector blade having a flexible wireframe covered by a cloth barrier material.
36. The system of claim 35, wherein the deflector blades are connected to the spacer via one or more arms.
37. The system of claim 35, wherein the flexible wireframe is configured to deform when positioned against the wall inside the patient's heart.
38. The system according to any one of claims 29-34, wherein the at least one deflector leakage control extension comprises one or more deflector blades and barrier elements.
39. The system of claim 38, wherein each of the one or more deflector blades has a flexible wireframe covered by a fabric barrier material.
40. The system according to any one of claims 38-39, wherein the barrier element comprises at least one of a cloth material, a biocompatible material, bovine or porcine heart tissue, and a plastic membrane.
41. A valve repair system for repairing a patient's native valve, the valve repair system comprising: Conveyor sleeve; A valve repair device capable of being deployed to the patient's native valve via the delivery sheath; The valve repair device includes: At least one anchor is configured to attach the valve repair device to the patient's original valve; At least one deflection leakage control extension extends from a portion of the device, wherein the deflection leakage control extension is configured to block retrograde blood flow from the ventricle to the atrium near or adjacent to the device during the heart's systolic phase, and is configured to allow blood to flow from the atrium to the ventricle through the deflection leakage control extension during the heart's diastolic phase. The at least one deflecting leak control extension is configured to bend toward the ventricle of the heart during diastole; The at least one deflecting leak control extension is configured to bend toward the atrium of the heart during systole; and The at least one deflection-type leakage control extension is configured to be positioned below the ventricular end of one or more leaflets of the original valve when the valve repair device is attached to the original valve.
42. The system of claim 41 further includes a coupling element.
43. The system of claim 42, wherein the at least one deflecting leak control extension extends from the engagement element and is configured to block retrograde blood flow along the side of the engagement element.
44. The system according to any one of claims 42-43 further includes a cap connected to the engagement element.
45. The system of claim 44, wherein the at least one deflection-type leakage control extension is connected to the cap, and the cap is connected to the engagement element.
46. The system according to any one of claims 44-45, wherein the at least one deflecting leak control extension is pivotally attached to the cap.
47. The system according to any one of claims 42-46, wherein the at least one anchor comprises a pair of blades coupled to the engagement element.
48. The system according to any one of claims 42-47, wherein the engaging element is configured to close the gap in the patient's native valve when the valve repair device is attached to the native valve.
49. The system according to any one of claims 41-48, further comprising at least one snap fastener, wherein the at least one anchor and the at least one snap fastener are configured to attach the valve repair device to the patient's native valve.
50. The system of claim 49, wherein the at least one snap-fit is coupled to the cap of the device.
51. The system according to any one of claims 42-48, wherein the at least one deflecting leakage control extension includes a deflector blade having a flexible wireframe covered by a cloth barrier material.
52. The system of claim 51, wherein the deflector blade is connected to the engagement element via one or more arms.
53. The system of claim 51, wherein the flexible wireframe is configured to deform when positioned against the wall within the patient's native valve.
54. The system according to any one of claims 41-50, wherein the at least one deflector leakage control extension comprises one or more deflector blades and barrier elements.
55. The system of claim 54, wherein each of the one or more deflector blades has a flexible wireframe covered by a fabric barrier material.
56. The system according to any one of claims 54-55, wherein the barrier element comprises at least one of a cloth material, a biocompatible material, bovine or porcine heart tissue, and a plastic membrane.
